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Characterization of Immune Responses to Repeated Aspergillus fumigatus Exposures 
Amanda Dawn Buskirk 
 
Personal exposures to A. fumigatus are associated with a variety of adverse health 
outcomes, including invasive aspergillosis, allergic sensitization, and asthma. Due to the high 
rate of mortality associated with invasive disease in immunocompromised patients, most studies 
of A. fumigatus have aimed to characterize the immune responses in immunocompromised 
murine models. However, a larger portion of the population is affected by fungal-induced 
allergies and asthma and the immune mechanisms associated with exposure have rarely been 
studied in an immunocompetent model. These models do not accurately reflect the natural 
method of exposure to environmental sources of conidia, and may significantly impact responses 
between fungi and the host immune system. Furthermore, little is known about the mechanisms 
associated with fungal induced allergy and asthma. Persistence of antigen is believed to play a 
role in induction of these diseases. Melanin, an A. fumigatus virulence factor, protects conidia 
from innate clearance, leading to fungal persistence. However, it remains unknown if melanin 
influences the induction of A. fumigatus – specific allergy and/or asthma. In these studies, 
immunocompetent mice were repeatedly exposed to A. fumigatus wild-type (WT) or melanin 
deficient conidia via aspiration or dry conidial exposures via an acoustical generator. 
Histopathological analysis of lung sections showed moderate to severe inflammation in all 
exposed mice, regardless of the exposure method or melanin content of the conidia. Overall, 
flow cytometric analysis of bronchoalveolar lavage fluid was similar between the exposure 
methods. However, there were marked differences between WT and melanin-deficient exposure 
groups in many of the cell populations analyzed. Germination was evident in all mice exposed to 
WT conidia, despite the exposure method. However, melanin-deficient conidia did not 
germinate, and were also cleared more rapidly in both exposure groups. Enhanced clearance of 
the melanin-deficient conidia was evident in mice exposed via the acoustical generator when 
compared to the aspiration exposure groups.  Importantly, CD8+IL-17+ Tc17 cells were elevated 
above control groups in all exposed mice, regardless of the exposure method, though the 
numbers were significantly increased in mice exposed to WT conidia. This is a significant 
finding, as the presence of these cells has not been previously reported in the context of A. 
fumigatus-induced immune responses. Evidence also suggests that the induction of Tc17 cells 
may be influenced by WT germination. Taken together, the data presented in this dissertation are 
among the first to characterize the immune responses to repeated dry fungal exposures in 
immunocompetent animals. Because these studies proved the feasibility of the dry aerosol model 
for repeated exposures, future studies with different environmentally prevalent fungi can be 
adapted for use with the acoustical generator to provide more accurate analysis of immune 
responses following repeated dry exposures. 
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Due to the clinical impact of A. fumigatus-induced diseases, multiple animal models have 
been developed to characterize host-fungal interactions, identify cell types and mechanisms 
important in clearing the fungus, and develop better diagnostics for earlier detection leading to 
better prognoses. To date, most A. fumigatus animal models have focused primarily on the 
mechanisms of invasive disease in immunocompromised animals and use fungal suspensions or 
extracts for exposures; however, the impact of dry, A. fumigatus exposures, as occurs naturally, 
in competent subjects and the development of allergy and asthma remains uncharacterized. 
Despite the quantity of available information concerning host-fungal interactions; two important 
caveats remain: 1) Unnatural exposure models, and 2) a poor understanding of the phenotypic 
characteristics that may influence the development of adverse health effects including allergy 
and/or asthma. The primary hypothesis of this dissertation was that exposures to dry A. fumigatus 
conidia that more closely represent natural exposures would result in differences in the murine 
immune responses when compared to the conventional fungal suspension aspiration exposures. 
Further, melanin, a known A. fumigatus virulence factor, protects conidia from innate clearance 
leading to persistence within the host.  Thus, a secondary hypothesis was that murine exposures 
to melanized conidia would modulate immune responses, leading to a greater potential for the 
induction of allergy and asthma. In this dissertation, the goals were to: 1) develop an 
immunocompetent murine model of repeated aerosol exposures to dry fungal conidia that more 
closely resembles natural environmental exposures, 2) examine the impact of fungal 
melanization on the induction of an allergic phenotype, and 3) identify the fungal components 
that induce a specific antibody response against A. fumigatus conidia. 
 
I. Aspergillus fumigatus Overview 
 A. fumigatus exposures can lead to a variety of adverse health effects, making it an 
important pathogen with an enormous impact on human health (1). A. fumigatus is an 
environmentally ubiquitous fungus, commonly associated with decaying plant matter (2, 3). The 
fungus propagates through forming unicellular conidia (amerospores) that are 2-3 μm in diameter 
and emerge through the formation of a conidiophore from vegetative hyphae (2). The small size 
and aerodynamic nature of these amerospores allow them to be easily aerosolized and 
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disseminate over long distances following common environmental disturbances, such as wind 
and vibration (2).  
 The conidial cell wall is traditionally thought to be composed of four layers including a 
phospholipid bilayer, chitin, β-glucan, and mannose proteins. However, recent studies have 
shown that the outermost layer of A. fumigatus is composed of a rodlet layer that consists of 
hydrophobic proteins, rodlet A and rodlet B (rodA and rodB) (4). This layer has been shown to 
be immunologically inert (4-6). The rodA and rodB proteins bundle together to form fibers that 
are woven together on the surface of conidia and envelope an underlying melanin layer (4, 5). 
The melanin layer is composed of large biopolymers, extensively intercalated throughout the 
conidial wall. Melanins have been identified as a virulence factor in several fungal pathogens 
including A. fumigatus  and are responsible for the characteristic blue-green color observed in A. 
fumigatus conidia (7-12). Under the melanin layer is the conidial wall that is composed of 
carbohydrates, α- and β-glucans, chitin, galactomannans, and other polysaccharides (13). These 
compounds have been identified as pathogen-associated molecular patterns (PAMPs). Upon 
recognition by pattern recognition receptors (PRRs), PAMPs induce a cascade of events which 
shape and/or modulate the immune response(s) against the fungus (14). Specifically, recognition 
of β-glucans is known to suppress toll-like receptor- 4 (TLR-4) induced responses, while α-
glucans inhibit the production of IL-6 through TLR-2 and TLR-4 stimulation (15). 
Galactomannans were shown to diminish the activity of TLR-4 stimulation, but had limited 
effects on TLR-2. Chitin, however, does not appear to have immunomodulatory activity (15). 
 The vegetative growth phase of the A. fumigatus may be induced following deposition on 
environmental substrates that may include temperatures between 20-70°C, high water content, 
and substrates rich in sugars, proteins, and/or carbohydrates (3, 16, 17). Importantly, germination 
has been identified as an important component which directly affects the ensuing 
immuneresponse against the fungus (18, 19). Conidial germination begins as the conidia swell, 
lose their rodlet and melanin layers, and subsequently form germ tubes (3). During this stage of 
active hyphal growth, PAMPs become more accessible and numerous proteases, including serine 
proteases, alkaline proteases, and elastases, are produced by the fungus (20, 21). These proteases 
are secreted to aid in fungal anchoring and to degrade the substrate to release nutrients that can 
be utilized by the fungus. Further, during hyphal growth, mycotoxins, such as proteases and 
gliotoxin, are secreted which can have adverse effects on immune cells (21-23). A. fumigatus 
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produces many proteins that can be allergens (22, 24, 25). In general, these allergens are 
predominantly serine, aspartate, and alkaline proteases, matrix metalloproteinases, heat shock 
proteins, enolase, ribosomal proteins, and cell wall proteins (Table 1.1). However, the function 
of many of the 22 identified allergens remains unknown. 
 
Table 1.1 
A. fumigatus antigens (24, 26) 
Identity  Function  Response 
1, 3-β glucanosyltransferase  cell wall biosynthesis Th1/Treg 
&Th2 
β 1,6 glucan-chitin linkages cell wall biosynthesis Th1/Treg 
aspartic protease (Pep1p) secreted protease Th1/Treg 
metalloprotease (Mep1p) secreted protease Th2  
mycelial catalase I (Cat1p) secreted protease Th2 
superoxide dismutase (Sod1p) secreted protease Th2 
dipeptidylpeptidase V (Dpp5p) secreted protease Th2 
ribonuclease (RNUp) secreted protease Th2 
glycosylinositolphosphoceramide 
(GSL) B glycolipid Th2/Th17 
GPI-anchored 
lipophosphogalactomannan glycolipid Th2/Th17 
α 1-3 glucan polysaccharide Th1 
β 1-3 glucan polysaccharide Th1/Th17 
galactomannan polysaccharide Th2/Th17 
Asp f1 major allergen 1/ribotoxin Th2 
Asp f2 allergen 2 Th2 
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Asp f3 peroxisomal membrane protein Th1 
Asp f4 allergen 4 Th2 
Asp f5 metalloprotease  Th2 
Asp f6 manganese superoxide dismutase Th1 
Asp f7 allergen 7 Th2 
Asp f8 acidic ribosomal protein P2 unknown 
Asp f9/16 (Crf1) cell wall glucanase  Th1 
Asp f10 aspartic endopeptidase Th1/Treg 
Asp f11 
cyclophillin type peptidyl-prolyl 
isomerase Th1/Th2 
Asp f12 heat shock protein hsp90 family Th1/Th2 
Asp f13 allergen 13/cerato platanin (protease) Th2 
Asp f17 galactomannoprotein MP1/β-
glucanase 
Th1/Th2 
Asp f18 alkaline serine protease Alp2 Th2 
Asp f22 enolase Th1 
Aspf23 605 ribosomal protein L3 unknown 
 
II. Respiratory and Pathogenic A. fumigatus Diseases 
 Due to the ubiquitous nature of A. fumigatus, are routinely exposed up to 104 A. fumigatus 
conidia/m3 (2). This number can be increased in water-damaged buildings and occupational 
settings to greater than 1010 conidia/m3 (2). Repeated exposures to A. fumigatus have been 
associated with multiple diseases, including allergy, asthma, hypersensitivity pneumonitis (HP), 
allergic rhinitis, allergic bronchopulmonary aspergillosis (ABPA), and invasive aspergillosis (3, 
27-30).   
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Invasive aspergillosis 
 A. fumigatus-associated invasive diseases have been steadily increasing in association 
with the development of improved therapeutic interventions for immunosuppressed, critically-ill 
patients. Several factors contribute to the occurrence of invasive disease including prolonged 
neutropenia, transplantations (bone marrow and solid organ), human immunodeficiency virus 
(HIV), hematologic malignancies, chemotherapy, corticosteroid treatment, and other immune 
deficiencies. Overall, there has been a steady increase in the frequency of invasive fungal 
diseases from 1-7% between 1978-1992, while the diagnosis of invasive aspergillosis has 
increased from 17-60% of all mycoses identified at autopsy (31, 32). The incidence of invasive 
aspergillosis in the United States is 36 per million hospital patients, with neutropenic patients 
being particularly susceptible (32). Two different forms of invasive A. fumigatus disease have 
been characterized;1) chronic necrotizing aspergillosis and 2) invasive aspergillosis (3, 33). 
Invasive aspergillosis is the predominant form of invasive disease studied epidemiologically and 
in animal models.  
 
Aspergilloma 
Personal exposures to A. fumigatus can also result in the opportunistic colonization of the 
dermis, mucosa, and airways. The conditions associated with this include dermatitis, keratitis, 
and the formation of aspergillomas (34). While dermatitis and keratitis are considered the less 
severe forms of colonization, aspergilloma is a more serious form of persistent A. fumigatus 
colonization. Symptoms of aspergilloma  include labored breathing, cough, fever, weight loss, 
and haemoptysis, the latter of which is associated with mortality rates up to 26% (35, 36). A 
cavitary aspergilloma is defined by persistent colonization and the formation of a hyphal mass 
within the lungs or sinuses. This typically occurs in immunocompetent individuals. Cavities most 
commonly form in patients that have previously been diagnosed with tuberculosis, though 
cavitary aspergillomas have also been shown to form in those diagnosed with other pulmonary 
and lung-related diseases (35, 37). Importantly, the mechanisms associated with aspergilloma are 
poorly understood, though insufficient drainage of respiratory cavities is thought to be a major 
factor. Furthermore, treatment is problematic, as common antifungal agents often fail to clear the 
organism, and surgical excision of the hyphal mass is required (35). Therefore, aspergilloma 
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formation is unable to be prevented in patients with irregular lung structure, and once fungal 
persistence occurs, it is difficult to clear with current antifungal agents (35, 37).  
 
A. fumigatus-allergy and asthma 
While invasive fungal infections have been the primary focus of most research, there has 
been an increase in research on A. fumigatus allergy (25, 38) Fungal allergic sensitization has 
been reported to be between 6-24% in the general population, with reports of A. fumigatus-
specific allergy in 23-80% of asthmatic patients (25, 39-41). The prevalence increases to 44% in 
atopics, and up to 80% in asthmatic patients in the US (42, 43). Age is also a factor in the 
frequency of fungal allergies, as 45% of pediatric asthmatics suffer from fungal allergies, while 
this increases to 70% of adult asthmatics (44). A. fumigatus-specific allergies have been reported 
in up to 2.4% of the general population, and 5-27.6% of atopics, thereby highlighting its 
importance as a prevalent fungal allergen (42, 45). Allergic rhinitis, sometimes referred to as hay 
fever, is commonly exacerbated by A. fumigatus. Symptoms include sneezing, itching, 
rhinorrhea, and nasal congestion. Allergic rhinitis is mediated by type I hypersensitivity, is 
associated with a genetic predisposition (atopy), and often precedes the development of asthma.  
 
Allergic bronchopulmonary aspergillosis 
Allergic bronchopulmonary aspergillosis (ABPA) a complex allergic responses resulting 
from exposures to A. fumigatus (40).  The disease is characterized by hyperactive 
proinflammatory immune responses, and type I and III hypersensitivity reactions. ABPA does 
not result in fungal colonization. It occurs predominantly in chronic asthmatics and cystic 
fibrosis (CF) patients, with estimates of prevalence between 2-14% of corticosteroid-treated 
asthmatics and 7-15% of CF patients (40, 46). Other reports have indicated higher frequencies up 
to 40% in patients with chronic asthma, and up to 38% in acute asthmatics (40). Life-threatening 
ABPA has been reported in 12-40% of asthmatic patients (25, 40). Clinical symptoms used for 
ABPA diagnosis include asthma, immediate skin reactivity to A. fumigatus antigens, dilated 
bronchi in the inner two-thirds of the chest cavity, peripheral eosinophilia, and necrotizing 
pneumonia (3). Currently, the immunological mechanisms leading to the induction and 
immunopathogenesis of ABPA are not well understood; however, an imbalanced TH2 response, 
as well as genetic predisposition, has been hypothesized to drive disease induction and 
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progression (40, 46). To date, patient treatment has been hindered due to lack of consistent 
clinical diagnostic standards; therefore, an improved understanding of the mechanisms of ABPA 
induction are required to develop better diagnostics for clinical usage. 
 
Hypersensitivity pneumonitis 
A. fumigatus is also an etiological agent of hypersensitivity pneumonitis (HP), a rare, 
allergic, interstitial lung disease commonly associated with occupational exposures (47). HP 
occurs due to exposure to foreign antigens and results in chronic pulmonary inflammation. It has 
been reported in 2-13% of interstitial lung disease reports, with an annual occurrence of 30 per 
100,000 patients (47, 48). To date, the extent of exposure and the immunological mechanism(s) 
behind the induction of HP remain poorly understood.  
 
III. Host-Fungal Interactions/ Innate Immunity 
Humans inhale over 10,000 liters of air each day, containing numerous bacteria, viruses, 
fungi, toxins, allergens, and other pollutants (49). Since A. fumigatus conidia are ubiquitous, and 
routinely inhaled, it is necessary to review common immune mechanisms used for conidial 
clearance to begin to understand how exposures may result in the aforementioned disease states. 
Because inhalation is the predominant route of exposure, and the focus for the research presented 
in this dissertation, only the impact of A. fumigatus exposures on the pulmonary immune 
responses will be discussed. The first line of defense against A. fumigatus conidia is the innate 
immune system.  
 
Complement 
 The innate immune system contains opsonins, which are non-specific components that 
bind to different moieties on the surface of potential pathogens and mark them for removal by 
circulating phagocytes or directly induce microbial lysis. The role of complement in A. fumigatus 
clearance has been examined by several groups. The lectin and alternative complement pathways 
have been hypothesized to have functional roles in A. fumigatus clearance due to the high levels 
of accessible PAMPs, including glycoproteins and mannose in resting conidia. Formation of a 
membrane attack complex (MAC) has a minor role in the clearance of A. fumigatus conidia, 
possibly due to the thickness of the cell wall; however, the impact of complement, specifically 
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component C5, on recruitment of phagocytes is thought to be an important step in antifungal 
immune responses (50, 51).  
Ultimately, the amount of C3 that binds to the surface of a microorganism can 
significantly affect the binding, endocytosis, and degradation of conidia. As previously 
discussed, A. fumigatus particles can exist in three forms: resting conidia, swollen conidia, and 
hyphae, each of which are potential activators of the complement system. Studies by Kozel et al. 
indicate that resting conidia bind C3 molecules at a slower rate than swollen conidia or hyphae. 
Different complement pathways are activated based upon the fungal particle morphology (52). 
The alternative pathway is associated with resting conidia, while the classical pathway becomes 
activated upon conidial swelling and hyphal formation (52). This is likely due to the presence of 
anti-Apergillus antibodies that form against the antigens that become accessible following 
conidial swelling and hyphal formation. C3 binding is also effected by temperature, as binding is 
more efficient at body temperature (37°C) than at lower temperatures. Furthermore, binding of 
C3 induces a rapid interaction of resting conidia with phagocytic cells (within 30 minutes) and 
enhances phagocytosis. Depletion of IgG from serum has no effect on the binding of C3 to 
conidial surfaces, thereby demonstrating the importance of the alternative and potentially the 
lectin pathways (53).   
A. fumigatus has several mechanisms to prevent C3 binding, and subsequent complement 
activation, to the surface of conidia and subsequent. These mechanisms lend to the opportunistic 
pathogenicity of the fungus, as resting conidia from more pathogenic species of Aspergillus (A. 
flavus, A. fumigatus, A. niger, and A. terreus) tend to bind fewer C3 molecules than those less 
likely to cause infection (54). Factor H, along with Factor H-like protein-1 (FHL-1), and Factor 
H-related protein 1 (FHR-1),  are negative regulators of the alternative pathway that commonly 
bind to vertebrate cells, thereby inhibiting the formation of MAC on host cells. A. fumigatus 
conidia strongly bind Factor H, FHL-1, and FHR-1while hyphal forms are less likely to bind 
these molecules (19). The C4b-binding protein (C4bp), another regulatory molecule which 
blocks the cascade of the classical and lectin pathways, also binds to the conidial surface (55). 
Through binding of these complement inhibitory molecules to the surface of A. fumigatus 
conidia, the fungus actively prevents further activation of the complement cascade. This can also 
effect the recruitment of phagocytic cells to the site of the fungus. Additionally, A. fumigatus 
conidia can also bind plasminogen, a serum protein that when activated to plasmin has been 
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shown to have proteolytic activity against bacteria. Plasmin is important for the degradation of 
the proteinaceous extracellular matrix, allows for tissue invasion by microorganisms, and also 
degrades complement proteins that bind to the surface of conidia. By binding plasminogen, 
preventing its subsequent activation to plasmin, the conidia are protected from enhanced binding 
of complement factors (56).  
Hyphae, hyphal fragments, and germinating conidia also contain other molecules capable 
of evading complement. Hyphae produce an alkaline protease, Alp1, which can inhibit 
complement binding, and can also degrade complement proteins including C3, 4 and 5. Upon 
conidial swelling and germination, A. fumigatus also produces several factors, called 
mycotoxins, Some of these toxins are known proteases that function to degrade host-proteins 
involved in fungal clearance. A. fumigatus hyphal culture supernatant, containing Alp1, has been 
shown to cleave complement proteins C3, C4, C5, and C1q, as well as IgG (50). Further, Alp1 
can also degrade CR3, a complement receptor that mediates uptake by phagocytes (50, 57). 
Although many aspects of complement interaction with A. fumigatus have been characterized, 
much work remains to advance the understanding of the roles, interactions, and mechanisms 
involved in complement/fungal immune responses. 
 
Epithelial cells 
 A. fumigatus conidia first encounter with the respiratory epithelium following natural 
exposures. The rodlet layer is believed to bind to the extracellular matrix proteins, laminin and 
fibronectin. Several genes have been identified that contain putative glycophosphatidylinositol 
(GPI)-anchored proteins and N-terminal signal sequences that are hypothesized to play a role in 
the adherence of conidia to the extracellular matrix of the respiratory epithelium. The conidial 
wall also contains large quantities of carbohydrates, including glucans, galactomannans, and 
chitin which have been shown to mediate fungal adherence (58). Each of these factors has 
provided insight into the initial mechanisms involved in the binding of A. fumigatus conidia to 
epithelial cells.  Different types of epithelial cells also have different propensities to bind A. 
fumigatus conidia. Ciliated tracheobronchial epithelial cells do not bind conidia, whereas non-
ciliated epithelial cells internalize conidia into intracellular vesicles. Paris and colleagues also 
illustrated the ability of endothelial cells to endocytose A. fumigatus conidia (59). Using in vitro 
experiments with a primary nasal epithelial cell line, Botterel and colleagues showed that A. 
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fumigatus conidia were rapidly engulfed by nasal epithelial cells, and trafficked to a late 
endosomal-lysosomal compartment within 4 hours, but were not degraded by the cell. Despite 
not being cleared by the nasal epithelial cells, the engulfed conidia did not germinate within 20 
hours post-exposure (60). It has also been shown that in addition to A. fumigatus conidia binding 
extracellular matrix proteins; they also bind to A549 respiratory type II epithelial cells in a 
concentration dependent manner. This binding is enhanced in the presence of the 
proinflammatory cytokine, interferon-γ (IFN-γ) (61). Lung surfactant D protein prevented 
binding of conidia to epithelial cells (62). In the study, A. fumigatus conidia began to germinate 
and penetrate a confluent epithelial layer within 12 hours (63). Once internalized, conidia are 
bound within acidified phagolysosomes, where a small percentage is able to survive. Of the 3% 
of surviving conidia, 34% germinate within the phagolysosome by 24 hours post-infection and 
by 36 hours, these germlings may escape the phagolysosome, avoid host cell lysis, and form 
extracellular hyphae (64). Therefore, the germination reported by DeHart et al. was likely a 
function of germination of extracellular conidia (63).  
A major mechanism for the induction of invasive disease is permeation of the endothelial 
layer by actively growing hyphae. During germination, A. fumigatus also produce numerous 
proteases which degrade the tight junctions present in the epithelial layer that aid in colonization. 
In a study comparing the ability of A549 cells and human umbilical endothelial cells to 
internalize A. fumigatus conidia, it was shown that epithelial cells (A549) internalize 30% of 
bound conidia, while endothelial cells are capable of engulfing 50% of conidia (65). 
Internalization of conidia was most efficient at 37°C. This study indicated that endothelial cells 
are more efficient at internalizing conidia, which is likely a conserved characteristic used by the 
host as a mechanism to ensure pathogens that bypass the epithelial layer are less likely to invade 
the blood stream. Additionally, killed conidia were internalized at comparable levels, indicating 
that the interaction of conidia and epithelial or endothelial cells is through a heat-stable 
molecule, such as surface carbohydrates (65). Viable conidia induced injury of the endothelial 
cells, which was not noted in response to killed hyphae. Conversely, hyphae also induce 
significant endothelial cell tissue factor activity, which was not apparent in response to conidia. 
These results suggest that invasive infection likely arises from the ability of hyphae to invade 
and injure endothelial cells, as well as induce tissue factor activity through unknown mediators 
(66).  
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It remains unclear why A. fumigatus is able to colonize the respiratory mucosa. 
Modulation of host cell apoptosis is a common mechanism used by pathogenic microorganisms 
as a means of evading the host immune response. Studies examining the impact of A. fumigatus 
conidia on the induction of epithelial apoptosis have illustrated that numerous Aspergillus 
species inhibit apoptosis. The inhibition of host cell apoptosis is achieved by viable conidia, as 
killed conidia do not induce this effect. Furthermore, culture filtrates, containing fumagillin and 
helvolic acid, from clinical isolates of A. fumigatus inhibited ciliary beat frequency, as well as 
induced damage to the respiratory epithelium in vitro (67). These results suggest that A. 
fumigatus toxins may influence the ability of the fungus to colonize in the respiratory epithelium. 
Secreted proteases have also been shown to induce the production of proinflammatory cytokines, 
namely IL-6 and IL-8, in A549 respiratory epithelial cells.(68). Further, gliotoxin has been 
shown to reduce the survival of infected mice, indicating enhanced fungal virulence (69).  
Recently, conidia have been shown to bind to PRRs present on epithelial cells which 
leads to the production of proinflammatory cytokines. Specifically, activation induced the 
upregulation of TLR-2 and TLR-4, stimulation of the NF-κB pathway, as well as the release of 
proinflammatory cytokines, IL-1β and IL-6. Inhibition of TLR-2 and TLR-4 stunted the release 
of cytokines, which illustrated the importance of TLR recognition of conidia (70).  Balloy et al. 
reported that respiratory epithelial cells detect A. fumigatus conidia through TLR-2 and TLR-4 
and that germinating conidia are required for the production of IL-8 which occurs through the 
phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 pathway. Experiments using MyD88-
dominant -negative transfected cells illustrated that the TLR-MyD88 pathway is not required for 
the production of IL-8. However, this pathway was activated by the presence of germinating 
conidia, and led to NF-κB activation. Therefore, both the MyD88-dependent and MyD88-
independent pathways are activated by germinating conidia and are involved in IL-8 synthesis 
(71). These data show that fungal germination directly impacts the immune response, and begins 
with the respiratory epithelium, which is an area that will be addressed in this dissertation. 
Though numerous studies have highlighted the potential role for airway epithelial cells in 
priming the initial immune response against A. fumigatus, it is still not clear to what extent these 
cells play in the overall immune response. Data suggests that these cells are capable of inducing 
a proinflammatory response against conidia. However, it appears that these responses only occur 
following germination of conidia. These data suggest that A. fumigatus conidia have an innate 
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function that allows them to interact with epithelial cells, induce their own endocytosis, survive 
within acidified phagolysosomes, and thereby evade the ensuing immune response. The conidia 
utilize the epithelial cells for protection, and contain mechanisms that allow for germination and 
invasion from these cells. Further studies are required to examine any additional immune 
functions that epithelial cells may have, the impact of these responses on the overall immune 
response against A. fumigatus, as well as to establish further insights into the mechanism(s) 
associated with interaction of A. fumigatus conidia with these cells. 
 
Macrophages 
Macrophages within the lung, termed alveolar macrophages, are the first professional 
phagocyte to encounter inhaled particles or potential pathogens. As part of the initial innate 
immune response, these cells are responsible for engulfing microorganisms, killing them through 
several mechanisms, and producing and secreting cytokines to recruit other effector cells to the 
site of infection. These steps are crucial to mounting and shaping the immune response against 
potential pathogens, including fungi. Though there is a baseline presence of alveolar 
macrophages following exposure to A. fumigatus, these cells are actively recruited to the lung 
and peak by 72 hours (72). 
Fungal particles specifically bind to alveolar macrophages through interactions of the cell 
wall components (PAMPs), with the PRRs on the host macrophages. Three predominant PRRs 
known to play a role in the recognition of A. fumigatus are TLR-2, TLR-4, and Dectin-1, though 
others may be involved (73). The interaction between fungi and the specific PRRs was shown to 
be fungal-morphology specific. TLR-4 interacts primarily with resting conidia, TLR-2 with 
resting and swollen conidia, while Dectin-1 recognizes exposed β-glucans, binds on each form, 
but more efficiently to swollen conidia and hyphae. Thus, fungal recognition by macrophages is 
mediated through carbohydrate, mannose, and lectin moieties present on both conidia and 
hyphae (74). TLR-2 activation is necessary for optimal signaling, as macrophages from TLR-2 
deficient mice that were incubated with resting conidia or hyphae produced less inflammatory 
cytokines than control macrophages (75, 76). The release of TNFα by macrophages may also be, 
in part, mediated by unidentified serum components (77). These studies also illustrated the 
importance of the MyD88 signaling pathway in antifungal responses (76).  
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Recognition of A. fumigatus conidia and hyphae by PRRs on host cells leads to 
phagocytosis. With alveolar macrophages, A. fumigatus is phagocytosed using two different 
types of phagocytosis: 1) pseudopod formation around conidia, or 2) zipper phagocytosis of 
larger hyphae. Within 3 hours, >90% of conidia are internalized in J774 murine macrophages, 
and macrophages can contain up to 3 conidia (76, 78). The phagosomes rapidly fuse to early and 
late endosomes, leading to phagolysosome maturation and acidification within 3 hours, and 
>99% conidial killing within 12 hours (75, 76, 79). Once internalized, oxygen radicals are also 
rapidly produced (79). Inhibition of NADPH oxidases decreases the amount of ROS produced 
and inhibits conidial killing without impacting phagocytic abilities (73).  
Additionally, germinating conidia, through increased interactions between Dectin-1 and 
the newly accessible β-glucans, have been shown to induce neutrophil recruitment to the airways 
and stimulate the production and secretion of TNFα/MIP2 by alveolar macrophages, while 
resting conidia did not have this effect (80). TLR-2 and MyD88-mediated signals were shown to 
provide an additive contribution to the activation of macrophages by germinating conidia. 
Activation of macrophages results in the recruitment of neutrophils to the affected site. Alveolar 
macrophages are known to efficiently bind and engulf resting conidia; however, this interaction 
does not induce the production of proinflammatory cytokines. On the other hand, swollen 
conidia and hyphae are strong inducers of NFκB, significantly increasing the production and 
secretion of proinflammatory cytokines and ROS. This response is, in part, mediated by the 
activation of the Dectin-1 receptor (81). Dectin-1 is also able to stimulate the production of 
TNFα in the absence of TLR-2 or MyD88 signaling. Overall, these results indicate that the 
pulmonary immune response is directed toward metabolically active fungi, and ultimately the 
recognition of cell wall β-glucans by Dectin-1, to avoid unnecessary tissue damage that would 
result from the frequent inhalation of ubiquitous conidia (81, 82).  
Hyphal exposure to macrophages stimulates the production of IL-10 through a TLR-2 
dependent mechanism (76). It has also been shown that the function of TLRs is likely redundant 
in immunocompetent mice, as neutropenic mice with TLR-2, TLR-4, and MyD88 triple-
knockouts do not survive a pulmonary A. fumigatus infection (83). In the presence of 
neutrophils, however, TLR-2, TLR-4, or MyD88 knockout mice are not more susceptible to 
invasive aspergillosis than WT mice (84). Furthermore, mice lacking functional TLR-2 and 
TLR-4 showed severely impaired neutrophil recruitment (85). This illustrates an essential role 
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for TLR-2 and TLR-4 –mediated phagocytosis in the absence of polymorphonuclear cells 
(PMNs). Immunosuppression through corticosteroid administration negatively impacted 
macrophage function, leading to the decreased production of  IL-1α and TNFα, which led to a 
significant decrease in IL-6 and TNFα production (84).  
 Corticosteroids, often used for immunosuppression in patients, also inhibit ROS 
production, production of proinflammatory cytokines, and fungal clearance by macrophages (73, 
86). Importantly, these responses are species-specific to A. fumigatus and A. flavus, but not A. 
terreus nor A. niger (86). Some conidia are often associated with unsealed phagosomes, which 
likely leads to lung disease due to the rapid release of oxygen radicals (2). However, it is 
unknown if conidia have an innate mechanism that may prevent phagosome sealing. 
Additionally, gliotoxin has been shown to preferentially bind and inhibit rodent macrophage-
mediated phagocytosis of particulate matter, as well as induction of morphological alterations. 
Specifically, gliotoxin, at concentrations well below toxic levels, was able to affect glucose 
metabolism, macromolecular synthesis, and inhibit bactericidal activity in macrophages (87-89). 
Further, immunocompetent, naïve, Dectin-1-deficient mice are more sensitive to an 
intratracheal challenge with A. fumigatus than control mice, and exhibit greater than 80% 
mortality within 5 days of exposure. Alveolar macrophages from Dectin-1 knockout mice 
showed impaired fungal uptake and failed to produce proinflammatory cytokines and 
chemokines. This resulted in insufficient recruitment of neutrophils and uncontrolled fungal 
growth, as neutrophils primarily respond to germinated fungi (73). The requirement for dectin-1 
signaling has also been shown in vivo. Dectin-1 activation, through interactions with swollen 
conidia or hyphae triggers the greatest level of proinflammatory cytokine and chemokine 
production, i.e. TNFα, IL-1α and β, IL-6, CXCL2/MIP2, CCL3, MIP1a, KC, GCSF, and GM-
CSF. This resulted in the impaired cellular recruitment, and increase in fungal burden, which 
illustrates the importance of the β-glucan/Dectin-1 interaction (80).  
Different A. fumigatus particles also influence the production of the inflammatory 
response in different types of macrophages. Different types of macrophages, as identified 
through surface markers, are also known to differentially respond to A. fumigatus conidia. 
Classical monocytes (CD14+CD16-) inhibit conidial germination, yet secrete minimal TNFα, 
while CD14+CD16+ monocytes do not inhibit germination, but secrete large amounts of TNFα 
(7). Additionally, it has been shown that following infection, alveolar macrophages rapidly 
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express Arginase-1, which is a key marker used to identify alternatively activated macrophages 
(AAMs). Induction of AAMs was not dependent on Dectin-1 or MyD88 signaling, and was 
shown to have a protective role in the anti-fungal response (72). Overall, these studies have 
shown that depletion of macrophages in a murine model significantly increased fungal burden, 
highlighting the importance of alveolar macrophages in the innate immune response against A. 
fumigatus (72).  
Further studies have indicated that A. fumigatus can inhibit phagocytosis and 
phagolysosome acidification, and is able to escape the macrophage. A common immune evasion 
strategy used by pathogens is inhibition of host cell apoptosis. Swollen A. fumigatus conidia have 
been shown to inhibit macrophage apoptosis through inhibition of caspase-3, an important 
enzyme in the cell death pathway, though the mechanism for this is unknown (6). Other studies 
indicate that, upon intracellular formation of hyphae, alveolar macrophages may not be lysed by 
the fungus. Rather, the hyphae continue to elongate, and surpass the alveolar cell wall barrier 
without inducing cell death, as a potential means of minimizing the inflammatory response that 
ensues following cell lysis. 
Overall, these studies illustrate an importance for TLR-mediated macrophage recognition 
of A. fumigatus which results in proinflammatory cytokine production. These cytokines are 
responsible for recruitment of neutrophils, which is necessary for clearance of germinating 
conidia. These studies encompass both in vitro and in vivo studies. In the in vivo studies, 
aspiration or instillation exposures were conducted, which ignore the potential alteration in 
responses that may occur following exposures to dry conidia as opposed to fungal suspensions. 
This is an aspect that will be addressed in Chapters 3 and 4 of this dissertation. 
 
Neutrophils 
 Prolonged neutropenia is the predominant immune deficiency associated with the 
induction of invasive aspergillosis, highlighting the importance of this cell population in host 
defense against A. fumigatus. In contrast to alveolar macrophage depletion, which can be 
functionally compensated during fungal clearance, early recruitment of neutrophils is essential 
for defense against A. fumigatus. Neutrophils are recruited to the airways following exposure and 
their numbers peak between 24 and 48 hours post-exposure (72). Depletion of neutrophils within 
3 hours of exposure is associated with high mortality (90, 91). This implies that neutrophils, and 
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not necessarily alveolar macrophages, may be essential in host defense against A. fumigatus 
conidia. However, redundant mechanisms of alveolar macrophages and neutrophils may act 
synergistically to aid each other and enhance antifungal responses. Alveolar macrophages 
phagocytose and kill conidia, but not hyphae, whereas neutrophils are capable of mounting an 
anti-fungal response against both forms of A. fumigatus.  
Once recruited, neutrophils respond by phagocytosing conidia and hyphae, through 
mechanisms similar to those used by alveolar macrophages. Neutrophil-mediated fungal 
clearance occurs through 3 classical neutrophil responses (34). Upon phagocytosis of either 
fungal conidia or hyphae, neutrophils immediately begin producing ROS and phagolysosome 
acidification. Neutrophil ROS production is dependent upon signaling through the dectin-1 
receptor, as neutrophils of dectin-1 knockout mice have impaired ROS production (92). 
Additionally, neutrophils can undergo degranulation upon interaction with microbes. This 
involves the release of numerous antimicrobial compounds from cytoplasmic granules, including 
alkaline phosphatases, lysozyme, lactoferrin, defensins, serine proteases, and many others. These 
compounds function to kill extracellular microbes, and mice lacking one of these compounds 
exhibit decreased A. fumigatus killing. Importantly, these killing mechanisms are morphotype 
specific as resting conidia do not significantly induce neutrophil degranulation or respiratory 
bursts (93). A third method of neutrophil mediated killing is the release of neutrophil 
extracellular traps (NETs).  
NETs are web-like extracellular DNA fibers that contain antimicrobial compounds, such 
as serine proteases (94). Dying neutrophils release their DNA in an effort to trap extracellular 
microorganisms, while the antimicrobials within the NETs, as well as those secreted from other 
nearby neutrophils, degrade the organism.  The formation of NETs in response to A. fumigatus is 
a relatively new finding; therefore, the intricacies of this mechanism are actively being 
examined. However, human neutrophils have been shown to produce NETs in vitro and in vivo 
in response to A. fumigatus (94). NET formation is a mechanism used by the host to capture 
invading pathogens, and thus is maximal in response to A. fumigatus hyphal formation, though 
they are still produced, to a lesser extent, in response to resting and swollen conidia. Importantly, 
presence of RodA inhibits NET formation, which explains maximal NET formation against 
hyphae which do not have a rodlet layer. While NETs are decorated with fungicidal proteins, it 
has been shown that NETs do not play a major role in fungal killing. However, it has been 
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hypothesized that the main function of NET formation is to prevent further spreading of 
germinating fungi (94).  
Though neutrophils contain multiple mechanisms for fungal clearance, the production of 
ROS species is the predominant killing mechanism. For example, individuals with chronic 
granulomatous disease (CGD) have a mutation in the gene encoding NADPH oxidase, and 
therefore, do not produce ROS (95). These individuals are unable to effectively clear A. 
fumigatus and are susceptible to infection. A study examining the transcriptional profile of A. 
fumigatus conidia following incubation with neutrophils from CGD or healthy patients showed 
that there were increases in the mRNA levels of genes involved in degradation of fatty acids, 
peroxisome formation, and the glyoxylate cycle. These data suggest that conidia alter their 
metabolism to adjust to the host environment. Further, mRNA levels of genes encoding proteins 
involved in iron/copper assimilation were higher in normal neutrophils exposed to conidia than 
CGD neutrophils (95). Another study reported acute sensitivity to invasive disease in oxidase-
deficient humans and mice (96). The authors reported that neutrophils were recruited to the lungs 
rapidly following infection, and responded by phagocytosing conidia and facilitating 
extracellular killing of germinated hyphae through ROS dependent mechanisms (96). In addition, 
following pulmonary instillation of A. fumigatus conidia in BALB/c mice, neutrophils were 
recruited to the lung and formed functioning oxidase aggregates with conidia, which inhibited 
germination (97). In CXCR2-/-, involved in neutrophil recruitment,  or gp91phox -/-, a NADPH 
oxidase knockout model, mice had delayed neutrophil recruitment to the lung and increased 
germination in comparison to the BALB/c mice at 6 and 12 hours post exposure (97). In the 
gp91phox -/- mice, germination was extensive in neutrophils, yet negligible in alveolar 
macrophages. BALB/c mice also had increased peribronchiolar neutrophil accumulation, but no 
germination, while the CXCR2-/- mice contained germinating conidia at 6 hours, which was 
cleared by 48 hours, and also recruited fewer inflammatory cells. In contrast, gp91phox -/- mice had 
extensive hyphal formation by 6 hours which resulted in tissue invasion by 48 hours. This study 
suggests that, in addition to activity by alveolar macrophages, neutrophil recruitment and the 
production of ROS and oxidative-active aggregates are essential in preventing A. fumigatus 
conidial germination (97). 
While neutrophils are essential in the clearance of A. fumigatus, uncontrolled activity can 
lead to host damage and disease (98). Neutrophils are capable of contributing to allergic 
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phenotypes (99). Antibody-mediated neutrophil depletion following A. fumigatus exposures in a 
murine model displayed reduced AHR and airway remodeling. Further, transgenic 
overexpression of the neutrophil chemotactic molecule CXCL1 resulted in increased airway 
neutrophil recruitment but not other leukocytes, and worsened allergic responses. Depletion of 
neutrophils in this transgenic model alleviated the severity of allergy. Overall, these data 
suggests that neutrophil responses against fungi are tightly regulated, and that in some instances, 
neutrophils may actually contribute to fungal allergic diseases (99). 
Furthermore, neutrophils are resistant to gliotoxin-induced apoptosis (87). This is another 
potential mechanism used by the fungus to enhance survival and germination, due to restriction 
of immune cells that function to control tissue inflammation, thereby allowing the unaffected 
neutrophils to continually produce inflammatory mediators that lead to tissue destruction (87). 
Neutrophil-mediated phagocytosis can be blocked by gliotoxin due to the induction of significant 
actin cytoskeleton reorganization, which results in cell shrinkage and the loss of filapodia 
required for phagocytosis. Gliotoxin can also inhibit ROS production in neutrophils (100). In 
summary, gliotoxin can negatively affect the phagocytic and clearance abilities of circulating 
neutrophils, allowing for dissemination of A. fumigatus (101).  
Due to the requisite role for neutrophils in the efficient clearance of A. fumigatus conidia 
and hyphae, it is necessary to examine the role of these cells in shaping the overall immune 
responses following exposure in an immunocompetent animal model. Because most studies 
examine A. fumigatus pathogenesis in neutropenic mouse models of invasive infection, there is 
limited in vivo data available on the role neutrophils in the pulmonary immune responses. This 
will be addressed in the following chapters of this dissertation. 
 
Eosinophils 
 Eosinophils are granulocytic cells that combat parasitic and viral infections (98). The 
granules within these cells contain numerous antimicrobial components, including eicosanoids, 
ROS, major basic protein, and enzymes including RNases, etc. Upon activation of eosinophils 
within the affected tissue, and subsequent phagocytosis of a microorganism, eosinophils undergo 
degranulation and release the contents of the granules. Eosinophils also degrade the engulfed 
organism using mechanisms similar to macrophages and neutrophils (98). Further, eosinophil 
cell numbers are increased in allergy. Despite the link between repeated fungal exposures and the 
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induction of allergy, asthma, or ABPA, little information is available on the interactions of 
eosinophils by A. fumigatus. However, Bhatia et al. have shown that eosinophils are recruited to 
the lungs within 24 hours, and remain elevated until 72 hours post exposure (72). Increased 
eosinophil numbers remain for up to 2 weeks after exposure, though continuous presence of IL-5 
and IL-13 can lead to eosinophil persistence (72).   
It has been shown that murine eosinophils are required for the induction of an allergen-
dependent TH2 pulmonary immune response which is mediated by DCs and T cells (102). 
Recruitment of peripheral eosinophils to the lung-draining lymph nodes is required for 
accumulation of myeloid DCs, which induces antigen-specific T effector cell production. This 
process did not require the expression of major histocompatibility complex II (MHC II) on 
eosinophils (102). This data suggests that eosinophils have an accessory role, as opposed to 
direct T cell interactions, in the activation of antigen-specific T cells. Further, eosinophils are 
also able to uniquely suppress DC-mediated production of TH17 cells, and to a lesser extent TH1 
responses, thereby promoting TH2 polarization and the induction of A. fumigatus allergic 
responses (103).  
 Investigators have also examined the impact of fungal cell wall components on the 
immune response. To this end, the ability of chitin, a cell wall component associated with β-
glucans, to induce eosinophil-mediated allergy has been examined (102). Cell wall preparations 
from Aspergillus that had been isolated from house dust samples from homes of asthmatic 
individuals, was able to induce a heightened recruitment of eosinophils into the murine lung. 
This was blunted by the enzymatic degradation of chitin and β-glucans. The expression of 
chitinase in murine lungs resulted in significantly lower eosinophil recruitment following fungal 
exposure. Blocking the activity of the chitinase resulted in prolonged duration of eosinophilia in 
the lungs. These results suggest that chitin, derived from household environments associated 
with asthmatic patients, is capable of inducing eosinophilic allergic inflammation within the 
lungs, though exacerbation of this response may be potentially be impacted by the coexistence of 
β-glucans (102). 
 Though the presence of eosinophils within the lungs of A. fumigatus exposed animals has 
been documented, it remains unknown if the route of exposure impacts eosinophil levels and the 
induction of allergy/asthma. In the studies presented in Chapters 2 and 3, two different exposure 
routes are utilized and levels of eosinophils are examined.  
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Natural killer cells 
 Natural killer (NK) cells are innate immune cells with cytolytic functions, similar to T 
cells of the adaptive immune system. The hallmark feature of these cells is the native ability to 
recognize and respond to ‘non-self’ cells, as well as tumor or infected cells, without the 
prerequisite for priming and classical activation (98). NK cells do not require the genetic 
reassembly of surface receptors, as do T and B cells. Instead, the surface receptors for NK cells 
are a mixture of germ-line encoded receptors that signal an activation or inhibition status. A 
balance between these signals dictates the status and response of the cell, though these 
mechanisms are not fully understood (104). When NK cells encounter foreign cells, they secrete 
enzymes, such as granzymes and perforin, which attack the cell membranes of microorganisms 
and induce lysis. These cells are also known to produce large amounts of IFN-γ, activate 
macrophages, induce the up-regulation of MHC I on professional antigen presenting cells, and 
also have anti-proliferative effects on malignant and virally infected cells (104). Thus, NK cells 
play an important role in the induction of TH1 responses, which are important for the clearance of 
fungal conidia (104). Recent evidence indicates that NK cells may also develop a memory 
response against commonly encountered antigens, and may aid in shaping the overall adaptive 
immune response against invading pathogens (105).  
 There have been few reports on the role of NK cells on A. fumigatus pulmonary 
clearance. In an invasive aspergillosis murine model with neutropenia, MCP-1/CCL2 is up-
regulated in the lungs, which leads to the recruitment of NK cells (106). NK cells have also been 
shown to be the predominant cell type responsible for the production of high levels of IFN-γ 
(107). When MCP-1/CCL2 or antibody-mediated NK cells were neutralized, early NK cell 
recruitment was abrogated, yet there was no effect on the recruitment of other leukocytes. The 
inhibition of NK cell recruitment led to twice the mortality and greater than 3 times the fungal 
burden in the lungs of infected mice, which was independent of T and B cell activity (106, 107). 
These results indicated that NK cells are a major source of IFN-γ during early A. fumigatus 
infections, and therefore play a critical role in the early host defense against A. fumigatus (106, 
107). 
Due to the ability of NK cells to kill tumor and infected cells, there has been an increased 
interest in the adoptive transfer of these cells into hematopoetic stem cell transplant patients as a 
therapy to combat infection (108). Because stem cell transplant patients comprise a large 
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population of patients that are highly susceptible to invasive aspergillosis, studies examined the 
feasibility of adoptive transfer of NK cells. The authors reported that both un-stimulated and IL-
2 pre-stimulated NK cells were able to effectively kill A. fumigatus hyphae, but had no effect on 
resting conidia. NK cell-secreted supernatant and perforin were also able to kill A. fumigatus. 
Interestingly, the high levels of IFN-γ and granulocyte, macrophage-colony stimulating factor 
(GM-CSF) produced by activated NK cells were sequestered by A. fumigatus, indicating the 
immunosuppressive capabilities of the fungus. Due to the ability of NK cells to specifically kill 
hyphae, these results suggested that adoptive transfer of these cells into stem cell recipients may 
be beneficial in the context of invasive aspergillosis (108). 
 
Dendritic cells 
 DCs are the professional antigen presenting cell of the immune system, and are therefore 
responsible for shaping the overall adaptive immune response against invading pathogens. These 
cells are located just beneath the epithelial layer of the respiratory tract, and constantly monitor 
the lumen for potential pathogens. DCs recognize pathogens through PRR interactions similar to 
macrophages and neutrophils, by binding to microbial-specific PAMPs. Once activated, DCs 
internalize and degrade the pathogens into peptides. These peptides are loaded onto MHC 
molecules and trafficked to the surface of the cell. Once activated, the lectin receptor  CCR7, is 
up-regulated on the surface of the DC which results in homing to different lymphoid organs 
where antigen presentation occurs. Interactions between the MHC molecules and co-receptors on 
the DC with T and/or B cell receptors and co-receptors activate the adaptive cells for effector 
function and clonal expansion (98).  
 Fungal β-glucans are known to induce and enhance the maturation of DCs (109). 
Interaction of yeast glucan particles with bone marrow derived DCs (BMDCs) stimulated the 
secretion of TNFα, which was mediated through dectin-1. Activation of TLR-9 or TLR-2/1 with 
yeast glucan particles and TLR-specific ligands resulted in higher levels of secreted IL-10, and 
IL-1α while decreasing the levels of IL-1β, IL-6, IFN-γ-inducible-protein-10 (109). These results 
suggest that different fungal morphotypes have the capacity to alter the immune responses in 
DCs, and therefore, alter the ensuing immune response against fungi (110). Furthermore, viable 
A. fumigatus conidia induce monocyte-derived immature DC death within 6 hours. This 
coincided with germ tube formation, and resulted in the differential regulation of several fungal 
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genes including the up-regulation of genes involved in fermentation, drug transport, 
pathogenesis, Asp f 1 allergen, and responses to oxidative stress (111). This interaction also 
resulted in the up-regulation of DC genes involved in proinflammatory cytokine production. 
Overall, these data show that, in addition to the up-regulation of proinflammatory cytokines 
induced in A. fumigatus following incubation with macrophages and neutrophils, the fungus also 
specifically adapts to phagocytosis by DCs that enhance its survival (111).  
The interactions between DCs and A. fumigatus conidia or hyphae allows for 
internalization of A. fumigatus through phagocytosis and recognition receptors (112, 113). 
Pathogens commonly gain access through the aforementioned TLRs, as well as dendritic cell-
specific ICAM-3 grabbing non-integrin (DC-SIGN). DC-SIGN has been shown to specifically 
interact with clinical isolates of A. fumigatus, and may be important in the initial interactions 
between the fungus and the host immune system (114). DC phagocytosis occurs through 
different mechanisms, coiling phagocytosis for conidia and zipper phagocytosis for hyphae, 
which involves the cooperation of distinct fungal recognition receptors. Optimal DC 
phagocytosis occurs between 60-120 minutes following exposure and is dependent on 
opsonization. In contrast, hyphae are rapidly degraded within 2 hours following internalization 
by DCs. Importantly, gliotoxin production by hyphae can specifically bind to DCs which inhibits 
function and induces apoptosis, which directly affects antigen presentation and the formation of 
adaptive immune responses (87-89).  
Recognition of different fungal morphotypes leads to the production of different cytokine 
responses. Upon incubation with A. fumigatus, immature myeloid DCs produce IL-12p70 and 
IL-4 (111). Internalization of conidia by DCs results in production of proinflammatory cytokines, 
predominantly IL-12p70 (111). In contrast, DCs internalizing hyphae produce larger amounts of 
the TH2 cytokine, IL-4, while producing no IL-12. Furthermore, DCs are unable to kill conidia 
although conidial antigens are still processed and presented to T cells in the draining lymph 
nodes (112). Thus, conidial-bearing DCs induce the priming of TH1 CD4 T cells that produce 
large amounts of IFN-γ (115). DCs home to the draining lymph nodes or the spleen, following 
ingestion of A. fumigatus, through interaction of CCR7 on DCs and its ligands CCL19 and 
CCL21 (116). Due to the general inflammatory nature of fungal-activated DCs, this process can 
be detrimental to the tissue during the infectious process. It has been shown that CCR7 
deficiency in pulmonary DCs leads to the production of TNFα, CXCL-10, and CXCL-2, leading 
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to enhanced activation of these cells. Thus, in invasive aspergillosis models, adoptive transfer of 
CCR7 deficient DCs resulted in increased numbers of inflammatory DCs, leading to increased 
survival and less pulmonary injury (116).  
Invasive aspergillosis is associated with the accumulation of inflammatory DCs within 
the lungs which has been shown to be protective (117). In a murine model of invasive 
aspergillosis, challenge with killed or attenuated A. fumigatus conidia resulted in the enhanced 
accumulation of inflammatory, but not other subsets of DCs in neutropenic mice (117). This 
effect was not observed in non-neutropenic mice. These results suggest that the infiltration of 
inflammatory DCs was due to a mechanism independent of neutrophil-mediated killing, and 
likely due to the enhanced influx of these cells to the lung due to high levels of TNF expression 
in neutropenic mice. High levels of TNF expression led to a greater lung expression of DC 
recruiting ligand, CCL2 and CCL20 (117). Furthermore, plasmacytoid DCs (pDCs), a subtype of 
DCs known to produce large amounts of type I IFN, spread over hyphae and inhibit further 
invasive growth (118). This antifungal activity is due to secreted substances and does not require 
direct cell-fungus interactions. The fungus combats this response by secreting cytotoxic 
substances in an attempt to kill the pDCs. During this time, the pDCs release high concentrations 
of proinflammatory cytokines via TLR-9 independent mechanisms. These cells play a role in the 
anti-A. fumigatus immune responses, as large numbers of pDCs are recruited to the lung 
following pulmonary exposure to hyphae. However, in vivo depletion of pDCs led to increased 
invasive aspergillosis susceptibility (92).  Furthermore, deletion of monocyte-derived DCs 
reduces Th1 and enhances Th17, which leads to decreased clearance of fungal conidia (119). 
 In humans, DCs obtained from healthy volunteers have the capacity to phagocytose heat 
killed A. fumigatus conidia, which results in the up-regulation of maturation markers, including 
HLA molecules as well as the coreceptors CD80 and CD86 (120). These activated DCs display 
increased production of IL-12. DCs stimulated ex vivo with A. fumigatus antigen were also able 
to stimulate lymphocyte proliferation and the increased production of IFN-γ (120). Furthermore, 
the stimulated DCs were able to partially restore the antifungal capacity of lymphocytes 
following adoptive transfer (121). These results were further supported by another group that 
showed adoptive transfer of fungal-activated DCs can impact the outcome of infection, as these 
cells can activate protective, non-protective, and TReg cells (122). Overall, these results suggest 
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that adoptive transfer of ex vivo stimulated DCs may be a useful therapy for combating invasive 
infection in neutropenic hosts. 
 
IV. A. fumigatus-Induced Adaptive Immunity 
The adaptive immune response does not result in the rapid removal of foreign pathogens, 
due to the time required (7-10 days following initial exposure) for adaptive cells to be primed, 
activated, expand, and be recruited to the site of infection (98). T and B cells are the primary cell 
types of the adaptive immune response. APCs from the site of infection are homed to the 
secondary lymphoid tissues after ingestion and processing of microbes. At this site, APCs bind, 
through surface MHC-peptide complexes and co-receptors, to predetermined antigen-specific T 
or B cell receptors, leading to the activation and clonal expansion of the adaptive cells. These 
cells are then recruited to the site of infection where the cytokine environment controls which 
type of response the naïve cells will mount and which antibodies will be secreted. Thus, the 
innate response against the invading pathogen directly affects the type, level, and effectiveness 
of the adaptive response.  
 
T cells 
There are several types of T cells that play a role in the clearance or pathogenesis of A. 
fumigatus exposures. In general, CD4 effector cells with a TH1 phenotype, consisting of TNFα, 
IFN-γ, IL-12, and IL-1β, are required for the effective clearance of A. fumigatus conidia, and 
subsequent resistance to invasive infection (34, 123, 124). Susceptibility to invasive infection is 
associated with a decreased production of these cytokines, with an increase in IL-4 and IL-10, 
which are classical TH2 and TReg cytokines, respectively (123). In WT mice, pulmonary infection 
via i.t. challenge with A. fumigatus induces TH1, TH2, and TH17 responses simultaneously (110). 
Dectin-1 signaling in these mice also reduces IFN-γ and IL-12p40 production in the lungs, which 
leads to a decrease in T-bet expression, a TH1 transcription factor, in responding CD4 T cells. 
However, dectin-1 knockout mice disproportionately increase TH1 responses and decrease TH17 
differentiation. Responding CD4 T cells, in the absence of IFN-γ, IL-12p35, or T-bet, increase 
TH17 differentiation independent of Dectin-1 signaling (110). Furthermore, IL-17 production 
within the lungs is dependent on dectin-1, which is important because neutralization of IL-17 can 
impair fungal clearance (92). 
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 As humans are constantly exposed to fungi, it is important to understand the mechanisms 
that mediate T cell responses following repeated exposures, and how these result in 
clearance/protection vs. infection vs. allergy/asthma induction. In a C57BL/6 murine model of 
repeated intranasal A. fumigatus exposures, greater than 99% of conidia were cleared within 24 
hours. Importantly, repeated exposures did not lead to the accumulation of conidia or 
germination over time (125). A secondary exposure resulted in the early recruitment of 
neutrophils and TRegs into the lungs, though overall inflammation was minimal. Repeated 
exposures also resulted in the continual expansion of T cells within the draining lymph nodes. By 
four exposures, eosinophils and myeloid cell influx to the lungs peaked, and goblet cell 
hyperplasia/mucus production and fibrosis was observed throughout the response, and TH2 
cytokines were produced. Repeated exposures, up to 8, led to T cell activation and the 
development of TH1, TH2, and TH17 responses. Importantly, the numbers of CD4 T cells and 
TRegs did not affect the number of myeloid cells, which implies that CD4 T cells may function to 
reduce the innate inflammatory responses that are chronically induced following repeated 
exposures (125).  
While IL-17 expression is classically thought to be proinflammatory, and results in the 
recruitment of neutrophils to the area of infiltration, TH17 responses have been shown in the 
induction/exacerbation of fungal allergy (126). TH17 cells can differentiate in the absence of 
proinflammatory cytokines. However, in IL-17 deficient mice repeatedly exposed to A. 
fumigatus conidia, inflammation was reduced, predominantly affecting the influx of eosinophils 
as IL-17 is central in the extravasation of eosinophils from the blood (103). In these mice, 
conidial clearance was also enhanced, while TReg induction was dampened. Thus, these results 
indicate that IL-17 may be partly responsible for driving TH2 responses following repeated 
exposures (103).  
CD4 T cells also have the ability to develop into memory cells, which has important 
implications in developing better immuno-therapeutics. In a murine model of invasive 
aspergillosis, mice that survived the primary infection contained IFN-γ producing CD4 T cells. 
These mice were also resistant to subsequent infection (127). Mice that did not survive the 
infection had mounted an immune response that was characterized by the production of IL-4 by 
CD4 T cells, and had impaired antifungal neutrophil responses. Interestingly, when these mice 
were treated with soluble IL-4 receptor, greater than 70% of mice did not succumb to infection 
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and were also protected from a secondary A. fumigatus infection. Therefore, CD4 IL-4-
producing T cells play a key role in determining susceptibility to invasive A. fumigatus infections 
(127). A. fumigatus-specific CD4 TH1 cells also have the ability to confer cross-protection 
against Candida albicans due to the presence of a highly conserved immunogenic epitope from 
the A. fumigatus cell wall glucanase called Crf1 (128). This epitope can be presented by three 
common MHC II alleles, and induces a group of memory CD4 T cells that are cross-reactive 
with C. albicans. Because A. fumigatus and C. albicans are the two predominant fungal species 
associated with invasive infection in immunocompromised individuals, this information may be 
useful for developing cross-protective immunotherapies (128). 
 The concentration of conidia that are inhaled during exposures directly influences the 
type of immune response. In a murine model of A. fumigatus, exposure to fewer than 2 x 103 A. 
fumigatus conidia, which is more than 3 logs less than the aforementioned exposure studies, 
leads to the generation of a TH2 response and eosinophilia, hallmarks of allergic lung disease 
(129). Conversely, exposures to higher concentrations of A. fumigatus conidia (2 x 105) induce a 
neutrophil-mediated response that resulted in a TH1 cell predominant, proinflammatory response 
(129). IL-17A was produced despite the concentration of conidia used for exposures, illustrating 
the requirement for IL-17A in both inducing and controlling the inflammatory response. Notably, 
A. fumigatus conidial exposures led to invasive infection, even at the lowest concentration, in 
Rag-/- mice lacking mature T and B cells. In contrast, B cell deficient mice cleared conidia in a 
manner similar to WT mice, which indicates a role for T cells in protection against fungal 
dissemination (129). 
 Adaptive immune responses against A. fumigatus have predominantly focused on CD4 T 
cells, while CD8 T cells have been largely ignored. CD8 T cells are the classical effector T cells 
that respond to tumor cells and viral infections. Experiments with ovalbumin transgenic (OT) 
mice showed that sensitization of OT-I (CD8 T cells) with ovalbumin and A. fumigatus extracts 
promoted clonal expansion and IFN-γ producing cytotoxic cells, suggesting that A. fumigatus 
may have an adjuvant effect on production of effector T cells (130). Furthermore, experiments 
from our lab showed that repeated aspiration exposures using viable A. fumigatus conidia 
induced IFN-γ producing CD8 T cells (131). This population of cells was decreased in mice 
exposed to heat-killed or fixed A. fumigatus conidia, as well as A. versicolor, which is not able to 
germinate at 37°C. Furthermore, viable A. fumigatus conidia persisted within the lungs longer 
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than heat-killed or A. versicolor conidia. This correlated to increased maintenance of airway 
memory CD8 T cells (131). Overall, the precise role of CD8 T cells in A. fumigatus-mediated 
immune responses is unknown, though it is likely that these cells are critical in the induction of 
memory responses. 
Furthermore, due to the gliotoxin-induced apoptosis of macrophages and DCs, the A. 
fumigatus-specific CD4 T cell responses are also suppressed (87, 88). This toxin can also induce 
apoptosis in splenocytes, thymocytes, and mesenteric lymph node cells. Further, gliotoxin can 
selectively deplete mature lymphocytes within the bone marrow. It also specifically inhibits 
NFκB DNA binding in T and B cells, and has been shown to suppress functional T cell 
responses, leading to overall immunosuppression (132). Additionally, pretreatment of a mixed 
lymphocyte culture with gliotoxin results in decreased induction of cytotoxic T cells, even at low 
concentrations (87). In conclusion, toxins produced by A. fumigatus are extremely capable of 
negatively affecting each cell type involved in fungal clearance, and are a major factor that 
impacts the host-immune response against the fungus. 
Though much evidence on the role of CD4 T cells in A. fumigatus immune responses is 
available, there is limited information about the role of CD8 T cells. Furthermore, these 
responses are based on unnatural aspiration exposures in both immune-suppressed and 
competent mouse models.  Therefore, it remains unknown if the route of exposure to dry vs. wet 
conidia affects T cell populations and cytokine production. To address these caveats, CD4 and 
CD8 T cell populations were analyzed following repeated aspiration or nose-only dry aerosol 
inhalation and will be presented in Chapters 2 and 3 of this dissertation. 
 
B cells 
 Little is known about the role of B cells in anti-A. fumigatus adaptive immune responses. 
Healthy individuals have been shown to produce A. fumigatus-specific antibodies, including IgM 
and IgG (26). Those with fungal induced allergy and/or asthma have also been shown to produce 
IgE antibodies. Further, IgA antibodies have been identified in invasive aspergillosis patients, 
and to a lesser extent, asthmatics that tested positive to an A. fumigatus antigen skin-prick test 
(133). Passive administration of fungal-specific antibodies enhances fungal clearance. However, 
B cell deficient mice that effectively cleared a primary infection did not elicit a protective 
memory response during secondary infection. These results indicate that B-cell antibody 
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production play a role in the anti-fungal immune responses, though the mechanisms associated 
with fungal-induced antibody class switching and production, as well as the importance of B 
cells in the long-term immune response to repeated exposures remains largely unknown. 
Furthermore, identification of the fungal-specific immuno-dominant proteins/peptides that are 
responsible for specific-B cell activation and expansion has yet to be elucidated. This 
information would aid in developing improved diagnostics and immunotherapeutic options.  
 There is limited information available on the recruitment of B cells to the lungs following 
exposures to A. fumigatus. Furthermore, little is known about A. fumigatus-specific B cell 
responses in the lymph nodes, including fungal factors that affect the clonal expansion, class-
switching, and antibody production, and the impact of B cells on developing allergy. To address 
these unknowns, studies presented in Chapter 3 of this dissertation examined the presence of B 
cells within the lungs following multiple dry, A. fumigatus conidia exposures. Furthermore, B 
cells were also examined in mediastinal lymph nodes, and assessed for IgE production.  
 
V. A. fumigatus Melanins 
 Melanins are heterogeneous group of phenolic compounds that form large, 
macromolecular pigments that are extensively intercalated throughout the conidial wall (12). 
These pigments are responsible for the characteristic blue-green color of WT A. fumigatus 
conidia. As fungi are predominantly environmental microorganisms and plant pathogens, 
melanin functions to protect the conidia from ultraviolet light and ensures the integrity of conidia 
under the stress of turgor pressure (11, 12, 134). Within a mammalian host, however, melanin 
has several different functions which protect fungi from the host immune system (8, 134). As a 
result, melanin has been classified as a fungal virulence factor.  
Using melanin knock-downs and albino mutants, melanins have been shown to enhance 
conidial survival by quenching reactive oxygen species (ROS), and prevent binding of 
complement protein C3 to the surface of the conidia (135-139). Melanin also appears to protect 
the conidia from the innate immune system by preventing phagolysosome acidification and 
inhibition of host-cell apoptosis (77, 140, 141). Conidia from melanin mutants also exhibit 
decreased virulence in a mouse model of invasive aspergillosis (135, 136, 142). Additionally, the 
presence of melanin in A. fumigatus conidia has been shown to attenuate the host pro-
inflammatory cytokine response of human peripheral blood mononuclear cells, as the conidia of 
 30 
the albino mutant induce higher levels of IL-6, TNF-α, and IL-10 than wild-type conidia (143). 
Similar results have been shown with low melanin producing mutants of C. neoformans, as these 
conidia induce greater inflammatory responses and are cleared more rapidly, as well as induce 
greater CD4+ T cell responses and TNF-α levels. Furthermore, albino conidia are more 
susceptible to host-mediated killing, as these conidia are more rapidly degraded than WT (135). 
Though fungal melanins have been shown to influence the immune response against A. 
fumigatus in immunosuppressed mice, there is no evidence that demonstrates the impact of 
melanin following repeated exposures in competent mice and the role it may play in allergy 
induction. Since persistence of an antigen is one factor that leads to the induction of allergic 
responses, it was hypothesized that melanin may be an important element in the induction of 
fungal allergies. This hypothesis will be addressed by this dissertation. 
 
VI. Animal models 
Numerous animal models have been used to examine the impact of A. fumigatus 
exposures in vivo. In these models, common methods of exposure include: 1) exposure of 
animals using aerosol chambers, 2) intratracheal instillation, and 3) pharyngeal/intranasal 
aspirations to conidial suspensions and/or fungal extracts (reviewed in Templeton et al (144)). 
These methods have been employed for mouse, rat, rabbit, and guinea pig exposures. Although a 
multitude of available data has been obtained from animal models of A. fumigatus exposures, the 
information derived from these studies is confounded for several important reasons. Most models 
of exposure examine the pathogenicity of A. fumigatus in immunocompromised animals and 
focus predominantly on infection. To date, little is known about the A. fumigatus-mediated 
immune mechanisms associated with the induction of allergy and asthma.  Most importantly, the 
data acquired from those studies may not be accurate, as the exposure models used do not reflect 
natural exposures to A. fumigatus. 
 In many of these exposure methods, suspension of fungal conidia within saline is used. 
Fungal conidia contain multiple surface antigens. Upon suspension in saline, these surface 
antigens may be washed off and diluted. Dilution or removal of these surface antigens may alter 
the interaction of the conidia with immune cells, and in doing so, alter the ensuing immune 
response. Further, as was previously noted, an environment with high water content is often 
sufficient for activation of the fungal conidia. Initially, the conidia would begin to swell, which 
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would alter its surface structure and expose numerous PAMPs that had previously been hidden in 
the cell wall of a resting conidium. Accessibility of these different PAMPs by immune cells 
would result in the activation of different cell types, which could significantly alter the cytokine 
environment, the recruitment of inflammatory cells and lymphocytes, and could ultimately, 
impact the type of response that the host mounts against the fungus. Activation causes a change 
in conidial metabolism, which results in the production of several enzymes and proteins that are 
known to hinder the immune response against fungi (3, 34). Importantly, a small molecular 
weight (< 10 kDa), heat-stable toxin has been shown to be released from conidia of 
environmental and clinical isolates within minutes of liquid suspension. This toxin is distinct 
from hyphal toxins, and has been shown to decrease ROS production by macrophages (145). 
Since many of the immune mechanisms known to play a role in fungal immunity may be 
impacted by approaches using liquid extracts, it is vital to determine the impact of dry fungal 
aerosols on the pulmonary immune responses to fully understand how natural fungal exposures 
may impact these areas.  
Another caveat associated with A. fumigatus exposure studies is the lack of information 
using animals that have been repeatedly exposed. In many studies, immunocompromised animals 
are given a single conidial dose to model invasive aspergillosis. While invasive aspergillosis is a 
disease that remains the focus of the research community, the majority of the population is not 
immunocompromised. Those studies that use immunocompetent animals, commonly expose 
naïve animals a single time, and then sacrifice the animal to examine multiple endpoints. 
Therefore, the impact of repeated A. fumigatus exposures in immunocompetent models is under 
studied. As humans are exposed to approximately 104 conidia/m3 daily, with the potential to be 
exposed to larger concentrations in occupational settings, it is of interest to determine what type 
of immune response occurs following repeated exposures and how the concentration of conidia 
may affect these results (2).  
 Studies of the influence of dry fungal exposures on the immune response are limited. To 
date, one group has attempted to address the role of dry fungal exposures in murine model. 
Schuh et al. developed a dry-fungal aerosol exposure chamber and examined immune responses 
in mice that had previously been primed to induce allergy. In this model, mice were immunized, 
both subcutaneously and intraperitoneally, a single time with a commercial A. fumigatus fungal 
extract containing a heterogenous mixture of proteins from both conidia and hyphae using alum 
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as an adjuvant. Mice were then exposed to the extract, intranasally, once per week for three 
weeks. Following these exposures, mice were either exposed a single time to a suspension of 5 x 
106 conidia via intratracheal instillation, or were subjected to inhalation exposure up to three 
times at different intervals following the first inhalation exposure. Aerosols were created by 
directing a stream of air across a fungal culture plate. The nose-only ‘chamber’, which 
accommodated 3 mice total, was pre-coated with fungi for 10 minutes prior to actual exposures. 
A sample of the aerosol was examined under oil immersion, and the authors noted that this 
sample did not contain swollen conidia or hyphae. The inhalation exposures required mice to be 
anesthetized and subjected to nose-only exposures for ten minutes. The total number of conidia 
that the mice were exposed to was quantified post-exposure. These studies reported multiple 
differences, including an increase in the eosinophils and lymphocytes, antibody responses, and 
overall lung inflammation to dry-aerosols when compared to liquid involuntary aspiration. The 
authors also noted that dry inhalation exposures exacerbated the allergic asthma phenotype.  
 The Schuh et al. studies suggested that dry conidial exposures induced different, 
heightened immune responses following repeated exposures, thereby further demonstrating the 
overall importance of this project (146). However, there were several limitations associated with 
their model that will be addressed by this dissertation. In the forthcoming studies, using an 
acoustical generator dry aerosol exposure system, 1) the number of fungal particles aerosolized, 
2) of the appropriate size (2-5 μm in diameter), and 3) being deposited in the lungs can be 
monitored in real-time.  This allows for the determination of the length of the exposure based on 
the desired lung deposition concentration, a function that was not addressed using the Schuh 
exposure system (146). the Pitt-3 acoustical generator nose-only chamber allows for the 
exposure of 15 mice at a single time. The fungal conidia used for exposure are grown on rice 
grains, a natural substrate, not on a fungal enrichment medium as was done in the Schuh studies, 
which may significantly alter their protein profile. The growth of fungi on rice was previously 
developed by Sorenson et al. as a method that enables improved aerosolization of fungal conidia 
(147). In our nose-only unit, aerosols are composed of predominantly single conidia but not 
hyphal fragments and other fungal aggregates. Furthermore, the animals are not anesthetized 
during the exposures, so that their respiratory volume, depth of breath, can be quantified and is 




In Chapter 2, mice were repeatedly exposed to A. fumigatus conidia using pharyngeal 
aspiration to characterize the pulmonary immune responses following exposures in 
immunocompetent animals. Further, the impact of fungal melanization in these responses was 
also examined. Three different A. fumigatus strains from a clinical isolate were utilized in these 
studies: 1) A. fumigatus wild-type (WT) conidia or one of two different strains with mutations in 
the melanin production pathway 2) Δarp2 (tan), or 3) Δalb1 (white). Through these experiments, 
it was determined that the presence of melanin impacts the neutrophil and eosinophil responses, 
yet does not induce detectable specific antibody production following exposures. Further, as was 
previously shown in an invasive infection immunocompromised mouse model, the presence of 
melanin inhibits the clearance of the conidia. Most importantly, it is shown that the presence of 
melanin impacts the accumulation of Tc17 cells, a cell type that had not been previously 
associated with fungal exposures, yet may play an important role in the clearance of conidia.  
In Chapter 3, a nose-only exposure chamber is used to examine the impact of dry conidia 
on the murine immune response following repeated exposures. In these studies, the wild-type 
and melanin mutant conidia were used for exposures. Repeated exposures to each strain induced 
similar levels of inflammation, which was also comparable to the data presented in Chapter 2. 
Mice that were exposed to melanized fungi (WT) showed delayed airwayreactivity (AR) at 48 
hours post-exposure, while the Δalb1 mutant AR was higher at 24 hours post-exposure. 
Furthermore, in agreement with experiments from Chapter 2, melanized fungal conidia were 
more resistant to clearance, as a higher number of conidia are present at early time-points 
following the final exposure when compared to Δalb1 conidia.  Cellularity data from these 
studies show that exposures to dry conidia result in a mixed Th1/Th2 response in both the lungs 
and mediastinal lymph nodes. The presence of melanin also resulted in higher levels of Tc17 
cells over the time course of the experiment. Sera isolated from exposed mice also showed 
immunoglobulin reactivity to conidial extracts; however, each exposure group exhibited 
reactivity to different conidial antigens, despite a similar protein profile between the species.  
The final chapter of this dissertation will discuss the impact of the data on delineating 
several aspects of A. fumigatus exposures that have been previously overlooked using alternate 
exposure methods Through the use of melanin mutant conidia, the data presented here indicates 
that while melanin is an important A. fumigatus virulence factor in immunocompromised mouse 
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models, it does not appear to play a major role in the induction of an allergic phenotype in a 
mouse model of repeated exposures. Importantly, these are the first studies to show that Tc17 
cells are present and affected by the presence of conidial melanin and germination. Further, the 
utilization of a nose-only dry fungal exposure chamber allowed for collection of data that more 
accurately represents, in comparison to the data reported following exposure to fungal 
suspensions, the immune response that occurs following natural exposures to A. fumigatus 
conidia. Finally, sera from exposed mice led to identifying the IgG dominant components of A. 
fumigatus that may be important for fungal pathogenesis. The identification of these proteins 
may be used in the future to develop more reliable immunodiagnostic tests, as target for anti-
fungal therapies, or as potential components that may be used to develop vaccines to protect 
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Chapter 2  
Pulmonary immune responses to Aspergillus fumigatus conidia in an immunocompetent mouse 
model of repeated aspiration exposures
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INTRODUCTION 
 Filamentous fungi are ubiquitous, saprophytic microorganisms that acquire nutrients from 
decaying plant matter and other carbon-rich substrates. Conidia formed by these fungi can be 
aerosolized following environmental disturbance. Certain conidia are sized within the respirable 
fraction and can be inhaled and deposited deep within the lungs (1). In small numbers, these 
conidia are rapidly phagocytosed and degraded by alveolar macrophages with little 
immunological consequence (1, 2). However, repeated exposures to higher concentrations may 
lead to the persistence of conidia within the lung and induction of airway inflammation, fungal 
allergy, and asthma. 
 Among the filamentous fungi, the opportunistic pathogen Aspergillus fumigatus is an 
etiological agent of invasive aspergillosis, hypersensitivity pneumonitis, allergy, and asthma (2). 
A. fumigatus-associated diseases have been steadily increasing due to improved therapeutic 
interventions for critically-ill patients resulting in increased numbers of immunosuppressed 
patients that are highly susceptible to fungal infections. Due to the extreme clinical impact of 
invasive disease, the majority of A. fumigatus exposure studies have examined the pathogenicity 
of the fungus in immunocompromised mice models. However, there has also been a steady 
increase in the incidence of allergy, including fungal allergies, in the immunocompetent 
population (3, 4). A. fumigatus-specific allergy and allergic bronchopulmonary aspergillosis have 
been reported in 23-80% and 12-40% of asthmatic patients, respectively (4-6). As a result, a 
larger population is affected by fungal-specific allergies than by invasive disease. Therefore, in 
order to better understand fungal diseases, it is necessary to determine the factors that direct the 
development of protective and/or allergic immune responses to A. fumigatus. 
Previous reports have identified A. fumigatus-associated virulence factors including; 
thermotolerance, production of secondary metabolites (gliotoxin) and proteases, as well as cell 
wall-associated molecules such as α and β-glucans, galactomannans, and melanins (7). Melanins 
are large, polymeric pigments associated with the cell wall, and are highly resistant to acidic 
degradation, thereby contributing to the rigidity and integrity of the conidia. They are also 
responsible for the characteristic blue-green pigmentation observed in A. fumigatus wild-type 
(WT) conidia (8). Since fungi are primarily associated with external environments, melanin 
functions to protect the conidia from ultraviolet radiation and ensures the integrity of conidia 
under the stress of turgor pressure in plants (9-11).  
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Using melanin knock-downs and albino mutants, melanins were found to enhance 
conidial survival by quenching reactive oxygen species (ROS) and preventing the binding of 
complement protein C3 to the surface of the conidia (12, 13). Melanin also protects conidia from 
the innate immune system by preventing phagolysosome acidification and inhibiting host-cell 
apoptosis (13-16). Conidia from melanin mutants exhibit decreased virulence in a mouse model 
of invasive aspergillosis (16, 17). The presence of melanin in A. fumigatus conidia was shown to 
attenuate the host pro-inflammatory cytokine response of human peripheral blood mononuclear 
cells, as albino mutant conidia induce higher levels of IL-6, TNF-α, and IL-10 than wild-type 
conidia (18). Similar results were found with low melanin producing mutants of C. neoformans, 
as these conidia induce greater inflammatory responses and are cleared more rapidly, as well as 
induce greater CD4+ T cell responses and TNF-α levels (19).  
Because fungal melanins protect conidia from innate clearance mechanisms, the 
persistence of conidia within the lung could alter the pulmonary immune responses to enhance 
the induction of allergy, asthma, and/or hypersensitivity pneumonitis. In an attempt to address a 
major caveat mentioned in Chapter 1, the role of phenotypic characteristics in the induction of 
allergy and/or asthma, this study was completed to examine how melanin may influence the 
induction of allergic fungal responses. Multiple exposures were used in this study to resemble 
repeated environmental exposures. Two strains of conidia with melanin synthesis pathway 
mutations derived from a clinical isolate of A. fumigatus were used. The Δarp2 mutant has a 
single gene deletion for the tetrahydroxynapthalene reductase and exhibits tan pigmentation, 
while the Δalb1 mutant has an albino appearance as a result of deleting the gene coding for the 
polyketide synthase in the dihydroxynapthalene (DHN) melanin synthesis pathway (20). These 
studies characterized the immune responses to melanin-deficient conidia in immunocompetent 
BALB/c mice. For the first time, our results demonstrate a CD8+IL-17+ (Tc17) response and that 
conidia derived from melanin mutants resulted in increased eosinophilia and decreased 
neutrophils and CD8+ IL-17 (Tc17) responses, as well as increased conidial clearance at early 
time points.  
 
 48 
MATERIALS AND METHODS 
Growth and handling of fungi: 
Fungal strains (Aspergillus fumigatus B-5233 (ATCC 13073)- the wild-type (WT) parent 
strain, Δarp2, and Δalb1) were received as a gift from Dr. June Kwon-Chung (NIAID, Bethesda, 
MD) (20). Fungi were grown for 14 days on malt extract agar (MEA) plates at 25°C in low 
humidity conditions to minimize the production of hyphae. Fungal conidia were harvested from 
plates by applying 1 g of 0.5 mm glass beads (BioSpec Products Inc., Bartlesville, OK) and 
gently shaking. The bead/conidia mixture was collected in a tube and suspended in 1 ml sterile 
phosphate buffered saline, pH 7.4 (PBS). The beads were vortexed and the supernatant 
containing conidia was collected and enumerated using a hemocytometer. To avoid the loss of 
fungal antigens, the conidia were subsequently diluted in sterile PBS, without washing, to a final 
concentration of 4 x 107 conidia/ml (2 x 106 conidia/50 µl) for animal exposures, as previously 
reported (21). Fresh conidial suspensions were prepared from 14 day old cultures for each 
exposure.  
 
MALDI-qTOF MS analysis of melanin mutant conidia: 
For positive ion matrix-assisted laser desorption/ionization quadrupole time-of-flight 
mass spectrometry (+MALDI qTOF MS) analysis, conidia were harvested as previously 
described (22). Briefly, conidia (~ 1 x 108) isolated from three plates of each A. fumigatus strain 
were mixed with 100 μl of 0.1 mm zirconium beads (BioSpec, Bartlesville, OK) and 1 ml of 
50/50 acetonitrile/4% trifluoroacetic acid (TFA) in water. After three one-minute cycles of bead 
beating, the samples were centrifuged at 14,500 rpm for 10 minutes. The supernatant was mixed 
1:1 with 10 mg/ml α-cyano-4-hydroxycinnamic acid (50/50 acetonitrile/0.1% TFA) and 1 μl 
spotted on the target plate and allowed to air dry. MALDI–qTOF mass spectra were acquired 
using a MALDI–SYNAPT MS (Waters Corporation, Milford, MA) qTOF mass spectrometer 
capable of mass resolution (m/Dm) of 14,000 and mass accuracy of ±5 ppm. Spectra were 
acquired over the m/z range of 3000 to 14000 u. Composite mass spectra were the result of a 6.5 
minute acquisition with the frequency-tripled Nd:YAG laser (355 nm) operating at 200 Hz, with 
the laser pulse energy maintained just above the threshold for ion production. Mass spectra were 
acquired using a predetermined ‘‘spiral’’ pattern that was held constant for all sample deposits, 
ensuring that a reproducible surface area was irradiated for each sample. 
 49 
 
Polyacrylamide Gel Electrophoresis:   
Conidial extracts were prepared by adding 2 ml of phosphate buffered saline/0.1% Tween 
to each of four plates and the conidia were agitated from the surface using a sterile inoculating 
loop. The conidial suspension was centrifuged at 2000 rpm for five minutes. The supernatant was 
discarded and the pellet containing the conidia was resuspended in sodium bicarbonate buffer 
(pH 8.0) and rocked at 4°C overnight. The sample was then centrifuged and the pellet was frozen 
at -80°C overnight, and lyophilized. Following lyophilization, the sample was mixed with 0.1 
mm glass beads and bead beat for three one-minute cycles using a mini bead-beater (BioSpec, 
Bartlesville, OK). Sodium bicarbonate buffer (2 ml) was added and the samples were again 
subjected to three one-minute bead-beating cycles, centrifuged, and the resulting supernatant was 
used for SDS-PAGE. Protein concentrations were determined using a BCA™ protein assay kit as 
per manufacturer’s instructions (Thermo Scientific, Waltham, MA). A 12% separating gel with a 
4% stacking gel was used for SDS-PAGE analysis. Conidial extracts (30 μg) were mixed with 
Laemmli’s sample buffer and heated at 95°C for 5 minutes. Samples were separated by 
electrophoresis for 90 minutes at 100 V. The separating gel was then stained using the Imperial 
Blue stain according to manufacturer’s instructions (Thermo Scientific, Waltham, MA). 
 
Field emission scanning electron microscopy: 
A 1 x 1 cm2 sample of agar was isolated from 14 day old culture plates of each A. 
fumigatus strain. The sample was air dried for three days, attached to an aluminum mount with 
double-stick carbon tape, and sputter coated with gold/palladium. Images were collected on a 
Hitachi (Tokyo, Japan) S-4800 field emission scanning electron microscope. 
 
Animals: 
Female BALB/c mice, aged 5-7 weeks (Jackson Laboratory, Bar Harbor, ME), were 
acclimated for approximately one week before initial exposures. The mice were housed in 
filtered, ventilated polycarbonate cages in groups of five on autoclaved hardwood chip bedding. 
The temperature in the animal facility was maintained between 68°F and 72°F and the relative 
humidity between 36% and 57%. The light/dark cycle was maintained on 12-hour intervals. 
Mice were provided NIH-31 modified 6% irradiated rodent diet (Harlan, Teklad) and tap water 
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ad libitum. Sentinel mice were free of viral pathogens, parasites, mycoplasmas, Helicobacter, 
and cilia-associated respiratory (CAR) Bacillus. The National Institute for Occupational Safety 
and Health (NIOSH) animal facility is an environmentally controlled barrier facility that is fully 
accredited by the Association for the Assessment and Accreditations of Laboratory Animal Care 
International. All animal procedures were performed under a NIOSH Animal Care and Use 
Committee approved protocol (protocol # 08-ST-M-015). 
 
Animal exposures: 
Mice were exposed to fungal suspensions by involuntary aspiration as previously 
described (23). Briefly, mice were anesthetized using isoflurane (Webster Veterinary Supply 
Inc., Devens, MA), suspended on a slant board, the tongue was held in full extension and a 50 μl 
suspension of 2 x 106 conidia placed at the base of the tongue. The tongue was restrained for two 
full breaths while the mice inhaled the conidial suspension. The anesthetized mice were then 
returned to the cage and allowed to recover.  
To assess responses to repeated exposures used to resemble repeated natural 
environmental exposures, mice aspirated 14 day old conidia twice per week for two weeks, 
rested for two weeks, and then challenged a final time (Figure 2.3A). Three days post-challenge, 
mice were sacrificed via an intraperitoneal (i.p.) injection of sodium pentobarbital (Sleepaway®, 
Fort Dodge Animal Health, Fort Dodge, IA).  
To examine the impact of innate immunity compared to adaptive immunity on the 
clearance of conidia, mice were either repeatedly exposed to conidia as indicated in Figure 2.3A 
(adaptive response), or mock-exposed with sterile saline twice per week for two weeks, rested 
for two weeks, and then exposed a final time to the indicated conidia (innate response). Mice 
were sacrificed at the indicated time points and lungs were removed and homogenized in sterile 
saline. Homogenates were plated in triplicate and incubated at 25°C for 24 hours. At this time, 
colony counts were visually determined. 
 
Histology: 
A group of five mice per fungal strain were repeatedly exposed as indicated in Figure 
2.3A. These mice were then sacrificed 72 hours post final exposure. The descending aorta and 
the inferior vena cava were severed, and then the lungs were perfused by injecting 5 ml of PBS 
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followed by 5 ml of 10% formalin buffered saline (FBS, Fisher Scientific, Fairlawn, NJ) into the 
right ventricle. No bronchoalveolar lavage fluid (BALF) was taken from these animals. The 
trachea was then exposed, nicked, and a catheter was inserted into the trachea. A syringe 
containing 1 ml of 10% FBS was then injected into the lungs, and the trachea was tied closed. 
The lungs were then removed and fixed in 10% FBS for 3-5 days prior to histological 
processing. Tissue processing, embedding, hematoxylin and eosin (H&E) and Grocott's 
Methenamine Silver (GMS) staining were performed by West Virginia University Tissue Bank 
(Morgantown, WV).  
 To assess the frequency of germinated conidia in lung tissues of mice exposed to fungal 
conidia, 150 fields of view from GMS stained mid-coronal sections of the lungs of each animal 
were examined for conidia, swollen conidia, and germ tube formation. Swollen conidia were 
defined by conidial swelling (2-3x normal size) as indicated in Appendix A3.  
 
Collection of BALF: 
For collection of BALF, the lungs were first perfused with 10 ml of PBS as indicated 
above, and then the trachea was exposed. Following nicking the trachea, a catheter was inserted 
and tied off with a suture to prevent leakage. A syringe containing 1 ml of PBS was attached to 
the catheter, the liquid injected into the lungs and subsequently removed. This process was 
repeated until 3 ml of BALF was collected.  
 
Flow Cytometric Analysis of BALF: 
Differential cell staining 
All reagents were obtained from BD Biosciences (BD Biosciences, San Jose, CA) unless 
otherwise specified. BALF cell composition was determined by flow cytometric analysis of 
recovered lavage cells in suspension. BALF was centrifuged for five minutes at 1500 rpm, the 
supernatant discarded, and the cell pellet resuspended and washed in 1 ml of FACS buffer (PBS, 
5% fetal bovine serum, and 0.05% sodium azide). The washed pellet was resuspended, and 
divided in half for cell enumeration and intracellular cytokine staining. One half of the cells were 
stained in FACS buffer, 10% rat serum, Fc-receptor blocking antibody (clone 24G2) and the 
following antibodies: rat anti-mouse Ly-6G FITC, rat anti-mouse Siglec-F PE, pan-leukocyte rat 
anti-mouse CD45 PerCP, and rat anti-mouse CD11c APC. After staining 30 minutes on ice in the 
 52 
dark, cells were washed with FACS buffer and fixed with BD Cytofix for 10 minutes. Cells were 
then washed and resuspended in FACS buffer for flow cytometry. Populations of cells were 
evaluated by flow cytometric analysis on a BD LSRII (BD Biosciences, San Jose, CA). 
Neutrophils were defined as CD45hiLy-6GhiCD11clow, eosinophils as Ly-
6GlowSiglecFhiCD11clow, and alveolar macrophages as Ly-6GlowSiglecFhiCD11chi, as previously 
reported (24). Total cell numbers were quantified from the BALF via hemocytometer counts. 
Total numbers of each cell population were obtained by multiplying the frequency of specific 
population by the total number of BALF cells recovered for each animal. 
 
Intracellular cytokine staining 
In a separate tube, BALF T-cells were quantified using rat anti-mouse CD8 FITC and 
CD4 PerCP antibodies. T-cell cytokine production was determined by fluorescent intracellular 
cytokine staining (ICS) as previously described (25). Briefly, the BALF suspension was 
centrifuged for five minutes at 1500 rpm and washed in 1 ml of RPMI 1640 complete medium 
(GIBCO, Grand Island, NY). The supernatant was discarded and a solution of Leukocyte 
Activation Cocktail with GolgiPlug in 0.2 ml complete medium was added to each sample for 
stimulation of cytokine production and simultaneous inhibition of cytokine secretion. Cells were 
incubated at 37°C in 5% CO2 for four hours. After incubation, the cells were washed in FACS 
buffer and stained for flow cytometry using rat anti-mouse CD4 PerCP and rat anti-mouse CD8 
FITC on ice in the dark for 30 minutes. Cells were then washed in FACS buffer and centrifuged, 
and the cell pellets were resuspended in BD Cytofix/Cytoperm for 10 minutes to allow for 
fixation and permeabilization required for subsequent ICS. Cells were washed with 1 ml of BD 
PermWash, and resuspended in PermWash. Each sample was divided equally into two tubes and 
stained with rat anti-mouse IFN-γ APC, rat anti-mouse TNFα PE-Cy7, and rat anti-mouse IL-17 
PE, or with control isotype antibodies (eBioscience, San Diego, CA). Cell were collected on a 
BD LSRII for one minute or until 50,000 events were recorded, with lymphocytes gated on the 
basis of low forward and side scatter, then subsequently gated on CD4+ or CD8+ populations to 
determine intracellular expression of cytokines. 
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Data Analysis Methods: 
Analysis of flow cytometric samples was performed with FlowJo software (TreeStar, 
Ashland, OR). GraphPad Prism was used for generation of graphs and statistical analysis for 
clearance and conidial germination experiments (GraphPad Software, La Jolla, CA). The data 
were analyzed via two way analysis of variance (26) followed by Bonferroni post-test. Statistical 
analysis of intracellular cytokine producing cells was performed using SAS version 9.2 for 
Windows (SAS, Cary, NC). The data were log transformed prior to analysis and ProcMix was 
used to run a one way analysis of variance (26) with ‘experiment’ included as a random factor to 
measure statistical significance. Differences between experimental groups that resulted in a p 




MALDI mass spectra of melanin-deficient conidia are the same as wild-type A. fumigatus 
 Although the genetic alterations in the melanin pathways of the strains used in this study 
have been previously characterized, it is unknown if the gene deletions in the melanin mutant 
conidia impacted other proteins that could potentially alter the immune responses to these 
conidia. Therefore, the MALDI 'fingerprint' mass spectra of extracts from conidia of each strain 
were examined. We have previously demonstrated the utility of mass spectrometry to 
'fingerprint' fungi for species and strain-specific discrimination (22, 27, 28). Figure 2.1 A-C 
shows the +MALDI qTOF MS fingerprint mass spectra for the different A. fumigatus strains. 
The mass spectra show the presence of multiple peptide/protein peaks, with prominent peaks at 
4840, 7875, and 8575 u. These mass spectra are in good agreement with the A. fumigatus spectral 
fingerprint previously reported (22). The peak height of protein/peptide signals in the Δalb1 
mutant strain spectrum were greater than those of the WT and Δarp2 spectra (Supplemental 
Appendix A1); consistent with previous observations that fungal-derived pigments suppress the 
desorption and/or ionization process during MALDI-TOF MS analysis (29).  
 In addition to high resolution +MALDI qTOF MS analysis of the <15 kDa mass range, 
SDS PAGE was additionally performed to identify potential differences that may occur between 
high molecular weight proteins of the different strains. As illustrated in Figure 2.1 D, the protein 
patterns of equally loaded melanin-deficient mutant conidial extracts is similar to that of WT A. 
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fumigatus. The protein profile for each of the strains, however, does contain observable 
differences in the density of some bands that are less than 30 kDa size range. These results 
suggest that global protein synthesis was not significantly altered by the gene deletions in the 
melanin-deficient conidia.  
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Figure 2.1. +MALDI qTOF MS fingerprint mass spectra 
 
 
Figure 2.1. +MALDI qTOF MS fingerprint mass spectra. A) A. fumigatus WT B) Δarp2 and C) 
Δalb1. Spectra are representative of three independent fungal cultures. Spectra are presented on 
fixed y-axis (% relative abundance) and optimized between the m/z range of 3000-14000 u. D) 




Melanin-deficient conidia retain the Rodlet A layer 
 The interaction of fungi with immune cells occurs through the interaction of pattern 
recognition receptors (PRRs) on host immune cells and the pathogen-associated molecular 
patterns (PAMPs) on fungal conidia and hyphae. Non-germinated A. fumigatus conidia contain a 
hydrophobic protein layer termed the Rodlet A (RodA) layer. This layer is immunologically inert 
and has been shown to protect the conidia from innate immune recognition by masking the 
PAMPs and preventing recognition by the innate immune system (30). Therefore, it was 
necessary to determine if the melanin-deficient conidia retained the RodA layer to ensure that 
any differences in the immune responses were not due to the differential accessibility of 
immunostimulatory cell wall components masked by the RodA layer. Field emission scanning 
electron microscopy (Figure 2.2 A-C) showed the surface of the albino (Δalb1) conidia appeared 
smoother than that of WT or Δarp2; however, this melanin mutant strain retained a RodA layer 
similar to that observed in WT conidia. Taken together with the mass spectrometry data and 
SDS-PAGE analysis, these data suggest that these strains differ primarily in melanin content. 
 
Figure 2.2 Field emission scanning electron microscopy images.   
 
 
Figure 2.2. Field emission scanning electron microscopy images.  A) WT, B) Δarp2, and C) 
Δalb1 conidia showing the presence of the RodA layer. 
A C B 
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Repeated exposures to A. fumigatus DHN-melanin-deficient conidia results in similar 
pathological inflammation compared to wild-type conidia. 
 Next we sought to determine if there was a difference in the inflammatory response 
following exposures to WT, Δarp2, or Δalb1 mutants using immunocompetent BALB/c mice. 
Mice were repeatedly exposed to conidia via pharyngeal aspiration as indicated in Figure 2.3A. 
This exposure method was initially used due to the large quantity of historic data showing high 
reproducibility and efficiency for the pulmonary delivery of fungal conidia. Moderate to severe 
inflammation and airway remodeling, resembling hypersensitivity pneumonitis, were evident in 
all mice regardless of the A. fumigatus strain (Figure 2.3 B-E). The extensive granuloma 
formation, mucus production, bronchoalveolar lymphoid tissue (BALT) induction, and goblet 
cell hyperplasia were histologically similar between the three exposure groups. 
 
Melanin-deficient conidial exposures result in different polymorphonuclear leukocyte responses.  
 Airway cellularity following exposures was examined in BALF by flow cytometry. Total 
cell numbers were comparable between exposure groups; however, Δalb1 conidia exposures 
induced fewer numbers of neutrophils (Figure 2.3 F-G). There was a concomitant increase in 
eosinophils in this group of animals (Figure 2.3 H). Interestingly, eosinophils were also 
significantly increased in mice exposed to Δarp2 conidia when compared to WT exposed mice 
(Figure 2.3 H). However, this increase in eosinophils did not correlate to the production of a 
serum antibody response, as no increase in total IgE or fungal-specific IgG antibodies could be 
















Figure 2.3. Exposure schedule and characterization of lung inflammation in repeatedly exposed 
mice. A) Exposure schedule and representative H&E stained lung sections from exposures to B) 
saline only, C) WT conidia, D) Δarp2 conidia, and E) Δalb1 conidia. Graphs indicate total 
polymorphonuclear cells in BAL from exposed mice. F) Total cell numbers, G) neutrophils, and 
H) eosinophils. Data are presented as the average ± standard error of measure of four 
independent experiments. N=20 mice/group. SAL= saline only exposures. Statistical differences 





























































CD8+ IL-17+ T cells are elevated in the lungs of mice exposed to Δalb1 DHN-melanin-deficient 
conidia. 
 To determine if there were differences in T-cell mediated responses to melanin-mutant 
strains, BALF was analyzed for T cells and intracellular cytokine production using flow 
cytometry. There was a decreasing trend in CD8+ T cell numbers that correlated with a decrease 
in melanin production. However, there was no significant difference in CD4+ or CD8+ T cell 
numbers (Figure 2.4 A and E). Additionally, there was no significant difference in CD4+ T cell 
cytokine production of IFN-γ and IL-17 (Figure 2.4 B and C). An increase was observed in CD4+ 
TNFα production, though this result was not statistically significant (Figure 2.4 D).  
 CD8+ T cell IFN-γ production was slightly elevated, but was not statistically significant, 
in mice exposed to Δalb1 conidia (Figure 2.4F). Interestingly, there was a significant decrease in 
the Δalb1 induced Tc17 cell population when compared to both WT and Δarp2 exposure groups 





Figure 2.4 T cell cytokine production following multiple aspirations. 
 
Figure 2.4. T cell cytokine production following multiple aspirations. CD4+ and CD8+ T cell 
cytokine production in the BAL of mice exposed to WT, Δarp2, or Δalb1 conidia. CD4+ and 
CD8+ T cells, CD4+ and CD8+  IFN-γ+. Data are presented as the average ± standard error of 
measure of four independent experiments. N= 20. CD4+ and CD8+ IL-17+ and TNF-α+, N= 10 
mice/group.  A) CD4+ T cells, B) CD4+ IFN-γ+, C) CD4+ IL-17+, D) CD4+ TNF-α+, E) 
CD8+ T cells, F) CD8+ IFN-γ+, G) CD8+ IL-17+, and H) CD8+ TNF-α+. Statistical 
differences are indicated by asterisks * p ≤ 0.01 as determined by one-way ANOVA. 
 
Melanin-deficient conidia are cleared more rapidly from the airways of both sensitized and non-
sensitized mice. 
 Histological examination of samples from repeatedly aspirated mice demonstrated that a 
larger number of WT conidia remained in the lungs of mice at the time of sacrifice than in mice 
exposed to the melanin mutant conidia (Figure 2.5 B-D and Supplementary Table 1-Appendix 
Table A3). Additionally, there were greater numbers of swollen conidia in the WT (7% swollen 
conidia) and Δarp2 (3.8%) exposed mice than in Δalb1 (1.5%) exposed mice. A higher 
frequency of germ tube formation was also observed in mice exposed to WT and Δarp2 conidia. 
No germ tubes were identified in any of the mice exposed to Δalb1 conidia (Figure 2.5E). These 
results were not due to differential viability, as each fungal strain exhibited similar viability prior 
to aspiration (data not shown).  
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Figure 2.5. Conidial germination in the lung tissue of mice repeatedly exposed as indicated in 
Figure 2.3A. GMS stained lung section following exposures to A) saline only, B) WT conidia, C) 
Δarp2 conidia, and D) Δalb1 conidia. Black arrows indicate swollen conidia (2-3X the size of 
resting conidia). White arrows indicate the formation of germ tubes. E) Quantification of total 
conidia, swollen conidia, or germ tube formation in WT, Δarp2, and Δalb1 exposed mice. N=4 
mice for WT and Δalb1, N=5 mice for Δarp2. Statistical significance is indicated by asterisks, 






To determine the lung clearance kinetics of each strain, we compared mice that were 
aspirated a single time (innate response- 4 exposures to saline only and challenged with conidia) 
to mice repeatedly aspirated (adaptive response- exposed as indicated in Figure 2.3A). The 
number of WT conidia remaining in the lung was significantly greater than Δarp2 and Δalb1 
conidia at 5 hours post final exposure in both single and repeated exposure mice (Figure 2.6). By 
24 hours post final exposure, greater than 94% of conidia were cleared in both single and 
multiple exposure mice despite the presence or absence of melanin (Figure 2.6). By 72 hours, 
more than 99% of the fungal conidia were removed from all mice, irrespective of melanin 
content. Interestingly, there were greater numbers of conidia remaining in the lungs of mice that 
repeatedly aspirated conidia at the 24 and 72 hour time points when compared to single exposure 





Figure 2.6 Rate of conidial clearance in exposed mice. 
 
Figure 2.6. Rate of conidial clearance in exposed mice. Mice were exposed to WT, Δarp2, or 
Δalb1 conidia and sacrificed at the indicated time points. At this time, lungs were removed, 
homogenized, and plated on MEA to determine fungal CFUs. Left panel shows clearance 
following a single conidial exposure in mice mock-exposed to saline 4 times and then challenged 
with the indicated fungal strain. Right panel shows adaptive clearance in mice repeatedly 
exposed to conidia as indicated in Figure 3A. Data are presented as the average ± standard 
error of measure of two independent experiments. N=10 mice/group. Data from each strain were 
normalized to the total amount of conidia obtained from mice sacrificed immediately after 
exposure. N=5 mice/group. Statistical significance is indicated by asterisks, *** p < 0.0001, ** 






Although A. fumigatus is known to cause human disease, the fungal-specific factors that 
contribute to pulmonary immune responses, protection from infection, and allergy induction in 
immunocompetent hosts have not been completely elucidated. Fungi produce proteases that are 
common allergens, however, the role of other components that contribute to the development of 
fungal allergies have largely been ignored (2, 31, 32). Fungal melanin has been shown to be an 
important virulence factor in invasive aspergillosis models, yet there is no information on the 
role of melanin on the development of allergic responses in an immunocompetent animal model 
(16, 17). The present study aimed to determine the impact of A. fumigatus conidial melanization 
on the pulmonary immune response in immunocompetent Balb/c mouse model.  Multiple 
aspiration exposures were used to resemble  continuous human exposures which can lead to 
allergy, asthma, or hypersensitivity responses (1). Though the central aim of this dissertation is 
to develop a murine model of repeated exposures to dry A. fumigatus conidia, the abundance of 
available information obtained from aspiration exposures made it an acceptable method for 
initial exposure studies. This also allowed for comparisons between dry conidia vs. conidial 
suspension exposures, and the ability to discern any potential differences between the two 
methods.  
 Previous studies have shown that the conidia from melanin mutant strains differ from WT 
conidia only in their melanin content and the smoothness of the outer cell wall surface (33). Our 
FESEM results confirmed that Δalb1 conidia have a smoother appearance (Figure-2.2). While 
there were observable differences in density of some SDS-page protein bands less than 30 kDa, 
there were no major differences in the protein profile of melanin mutant conidia compared to 
WT. Thus, the single gene deletions in the mutant strains did not appear to have an impact on 
global protein synthesis and it is unlikely that differential expression of potentially immune-
reactive proteins was solely responsible for the observed differences in the immune responses 
between the three strains. 
 A. fumigatus conidial walls are surrounded by an immunologically inert hydrophobic 
rodlet layer composed of RodA and RodB proteins with melanin polymers extensively 
intercalated throughout the wall (34). These layers help provide the conidia its structural rigidity. 
Importantly, the rodlet layer has been shown to protect the conidia from innate immune 
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recognition by PRRs. Previous reports have shown that in vitro exposure of primary dendritic 
cells and macrophages to the RodA protein did not induce cellular maturation/activation. RodA 
did not stimulate the production of inflammatory cytokines, antibody, or protect from infection 
in an invasive aspergillosis animal model.  However, ΔRodA mutant conidia or swollen WT 
conidia were highly inflammatory and capable of activating innate immune cells (30). 
Previous studies have shown contradicting results concerning the presence of RodA layer 
in melanin-deficient A. fumigatus conidia (8, 15, 33). Pihet et al. used atomic force microscopy 
to examine the conidial surfaces of naturally-isolated A. fumigatus melanin mutant conidia and 
reported the absence of the RodA layer in these strains (8). However, it is possible that other 
mutations independent of the melanin pathway may have affected the rodlet layer in this 
naturally occurring mutant.  Brakhage et al. examined the surface of laboratory-derived albino 
conidia, similar to the strain in the present study, using scanning electron microscopy and 
compared the conidial surfaces of WT and melanin-deficient conidia. In their studies the RodA 
layer remained intact in albino conidia (15, 33). Our results were similar, in that the rodlet layer 
was observed on the surface of the WT and each melanin mutant strain, with the rodlet layer of 
the albino mutants appearing in highly organized tight bundles. This finding is important as it 
suggests that the differences in the immune responses observed are potentially related to the 
difference in amount of melanin rather than any differences in accessibility of 
immunostimulatory cell wall components in dormant conidia, such as galactomannan or β-
glucan. It has been suggested that immunostimulatory PAMPs, that may impact early innate 
recognition and clearance, are more easily accessible on the surface of melanin-deficient conidia 
[23]. It is also possible that because of the lack of melanin, the albino or melanin knock-down 
strains over-compensate by increasing the concentration of other immune-modulatory conidial 
wall components. However, further studies are required to determine if these cell wall 
components remain hidden by the rodlet layer in melanin-deficient conidia (18). 
  In this study, we found that histopathological inflammation, granuloma formation, 
BALT induction, goblet cell hyperplasia, and airway remodeling were similar in each exposure 
group. Therefore, the presence of melanin does not appear to significantly impact lung 
inflammation. However, the melanin mutant conidia stimulated greater numbers of eosinophils 
in the airways indicating a shift in the type of immune response. Unfortunately, a serum antibody 
response was not detectable, specific IgG or total IgE (data not shown), thus a clear TH1 to TH2 
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shift was not apparent. It is probable, that because all conidia retained the rodlet layer which is 
resistant to proteolytic degradation, the production of antigens for processing and presentation 
was inhibited (30). Additional experiments to determine the extent that melanization impacts 
antigen presentation to B cells, and therefore antibody production, will be crucial to determine 
the mechanisms of pulmonary tolerance in response to fungi.  
 It has been previously shown that a TH1 response, consisting of CD4+ T cells and IFN-γ, 
is necessary for the efficient clearance of fungal conidia (2, 35). Therefore, we evaluated the 
production of cytokine responses in T cells to determine if a similar T cell response occurs in the 
repeated exposure model. While TNFα and IFN-γ are known proinflammatory cytokines 
required for protective immunity against fungi, the role of IL-17 in fungal immunology is 
relatively unknown (36). IL-17 is associated with chronic inflammation, autoimmune disorders, 
and allergy, and involved in the recruitment and subsequent activation of neutrophils and 
macrophages to the site of inflammation (37, 38).  The levels of CD4+ IFN-γ+, TNFα+, and IL-
17+ cells were increased by fungal exposures, yet comparable between WT, Δarp2, and Δalb1 
exposed mice. This indicates that the extent of melanization does not appear to affect these cells 
directly. 
Considerably less is known about the role of CD8+ T cells in immune responses to fungi. 
CD8+ T cell responses were shown to be partly dependent on germination, and play a role in 
fungal clearance and protection from infection, although their mechanism of protection remains 
uncharacterized (21, 39). In the present study, we did not see changes in CD8+IFN-γ+ cell 
recruitment, however, CD8+ IL-17+ (Tc17) cells were found to be decreased in mice exposed to 
Δalb1 conidia.  
Tc17 cells are a unique subset of CD8+ T cells that have recently  been associated with 
viral immunity (viral clearance), pulmonary inflammatory responses, patients with systemic 
lupus erythematosus, control of tumor growth, and contact dermatitis (40-44). Tc17 cells 
demonstrate functional plasticity, and are reported to produce proinflammatory cytokines and 
chemokines responsible for the enhanced recruitment of macrophages, natural killer cells, and 
neutrophils (40, 41, 45). These cells have not been previously identified in models of fungal 
exposures, and may indicate a novel role for Tc17 cells in the immune responses to fungi. This 




In allergic asthma models, IL17 has been associated with inflammatory pulmonary 
responses. In the C57BL/6J mice, eosinophil recruitment to the lungs was correlated to IL-17 
production [48]. However, in a BALB/c OVA allergy model, IL-17 depletion resulted in 
increased pulmonary eosinophilia (46). The disparity between these studies is likely due to a 
combination of the genetic differences between C57BL/6J and BALB/c strains and the exposure 
route or schedule, highlighting the importance of genetics and exposure protocols. Future 
experiments are needed to fully characterize the role of IL-17 in inflammatory cell recruitment in 
response to A. fumigatus exposures.  
 We also examined the ability of the mice to clear fungal spores from their lungs. Others 
have reported that A. fumigatus albino mutants are more rapidly phagocytosed and degraded than 
WT spores (16, 17, 33). However, this had not been examined in an immunocompetent animal 
model of repeated exposures. We observed that the clearance of Δarp2 and Δalb1 conidia is more 
rapid than in mice exposed to WT at 5 and 24 hours post-challenge. After repeated fungal 
exposures, however, the ability to efficiently clear conidia was reduced at the 24 hour time point 
compared to single exposure mice, irrespective of melanin content. In a study by Murdock et al., 
it was reported that 24 hours after the final exposure, repeated exposures did not enhance 
conidial clearance, though clearance at earlier time points was not measured (47). Protective 
tolerance to fungi, regulated through IL-10 and TReg cells, is induced by repeated exposures to 
limit inflammation and subsequent tissue damage (48-50). The presence of IL-17 has also been 
shown to inhibit A. fumigatus clearance (51-53).  In accordance with these studies, our decreased 
clearance results may correlate with the decreased Tc17 and airway neutrophil recruitment in 
response to Δalb1 conidia.  It may be possible that the repeated exposures in our model result in 
the induction of a tolerance response to lessen the extent of inflammation, and subsequent tissue 
injury over time, thereby resulting in a higher numbers of conidia remaining in the lungs of 
adaptive mice. Future experiments to examine IL-10, IL-17, and TReg cell responses and the 
production kinetics following repeated exposures to melanin-deficient conidia would aid in 
determining the mechanisms affected by the presence or absence of melanin. 
In summary, we have characterized the pulmonary immune response to repeated fungal 
exposures in an immunocompetent model and are among the first to have identified a Tc17 cell 
population following repeated A. fumigatus exposures. We have also shown that a lack of 
melanin in A. fumigatus conidia alters pulmonary immune responses (decreased Tc17 cell and 
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increased eosinophil cell numbers) and enhances conidia clearance, yet does not appear to impact 
the induction of antibody or allergic sensitization.  Although melanin has been shown to be an 
important virulence factor in invasive disease models, it appears to be less significant in disease 
pathogenesis in an immunocompetent exposure model. This is likely due to the efficiency of the 
intact immune system to clear most fungal conidia within 72 hours, regardless of their melanin 
content.  Importantly, this is the first study reporting the presence Tc17 cells within the lungs in 
response to fungal exposures, thereby suggesting a novel role for these cells in the immune 
response to Aspergillus fumigatus conidia.  
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Chapter 3  




Personal exposures to A. fumigatus are increasingly associated with a variety of adverse 
health outcomes including invasive aspergillosis, allergic sensitization, and asthma (1). The 
ubiquitous nature of this fungus in the environment, accompanied by the abundant production of 
small (2-3 µm) aerodynamic conidia may result in personal exposure up to 104 condia/m3 (2). 
The concentration of fungal exposure may even be higher in water-damaged buildings and some 
occupational environments (2). In immunocompromised hosts, exposure to A. fumigatus often 
leads to invasive diseases with high mortality (3). In immunocompetent individuals, repeated 
exposures to low concentrations results in rapid innate clearance of conidia. However, over the 
past two decades, there has been a steady increase in reported fungal-induced allergies and 
asthma (4, 5). To date, the fungal-specific factors and immunological mechanisms that lead to 
the induction of these allergic diseases are largely unknown. It has been hypothesized that 
repeated exposures to high concentrations of A. fumigatus in immunocompetent individuals 
result in fungal persistence within the lung, which may cause and/or exacerbate hypersensitivity 
pneumonitis, allergy, and asthma.  
Numerous murine models of fungal exposure have been developed to determine how A. 
fumigatus influences immune responses (6-22). These studies have provided insight into A. 
fumigatus immune responses, but the test articles have often consisted of uncharacterized 
extracts or liquid spore suspensions that do not resemble natural human exposures (6). The 
surface of conidia contains a number of potentially important immunostimulatory antigens that 
may be removed or diluted upon preparation of liquid suspensions. This may alter the interaction 
of conidia with immune cells, thereby modifying the subsequent immune response(s). 
Furthermore, high water content is necessary for A. fumigatus germination and suspending 
conidia in saline may prematurely activate the conidia (23). Activation of conidia significantly 
alters the surface structure and accessible antigenic molecules. Germination has been shown to 
significantly increase the expression of A. fumigatus antigens and allergens (24, 25). 
Germination also results in the production of several immunosuppressive mycotoxins that 
influence the immune response substantially (26-31). A. fumigatus conidia have also been shown 
to secrete a small toxin after short incubations in Hank’s Balanced Salt Solution that is 
immunosuppressive and distinct from known mycotoxins (32). Since many of the immune 
mechanisms known to play a role in fungal immunity may be impacted by the liquid exposure 
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method, it is vital to characterize the influence of dry fungal aerosols on the pulmonary immune 
responses, which is the primary aim of these studies. Thus, we hypothesize that these secreted 
antigens, allergens and mycotoxins produced during the preparation of fungal suspensions for 
instillation or aspiration exposures may significantly limit and confound previous murine models 
of A. fumigatus exposures. 
To date, there have been limited animal studies completed to ascertain the influence of 
dry fungal exposures on the pulmonary immune response. Schuh et al. developed a dry-fungal 
aerosol exposure chamber and examined immune responses in mice that had previously been 
primed to induce allergy (33, 34). In this model, mice were sensitized, both subcutaneously and 
intraperitoneally, a single time with a commercial A. fumigatus fungal extract that contained a 
heterogenous mixture of proteins from both conidia and hyphae using alum as an adjuvant. Mice 
were then exposed to the extract, intranasally, once per week for three weeks. Following these 
exposures, mice were either exposed a single time to a suspension of A. fumigatus conidia via 
intratracheal instillation, or were subjected to inhalation exposure(s) up to three times at different 
intervals following the first inhalation exposure (34). A. fumigatus aerosols were created by 
directing a stream of air across a fungal culture plate. The inhalation exposures required mice to 
be anesthetized and subjected to nose-only exposures for ten minutes. The total number of 
conidia that the mice were exposed to was quantified post-exposure. Interestingly, these studies 
reported multiple differences, including an increase in eosinophils and lymphocytes, antibody 
responses, and overall lung inflammation to dry-aerosols when compared to liquid involuntary 
aspiration. The authors noted that dry inhalation exposures exacerbated the allergic asthma 
phenotype (34).  
Although these studies provide support for our overall hypothesis that dry fungal 
exposures will result in similar, yet qualitatively different immune responses when compared to 
aspiration exposures, there are several limitations associated with their model. The studies 
presented in this chapter examined the ability of dry conidia to affect the immune response in 
pre-sensitized mice, thereby prematurely skewing the results toward a Th2 response. Further, the 
concentration of conidia was not able to be altered during exposures, and the exposure 
concentration was determined following sacrifice of the animal following exposure. These 
studies also required animals to be anesthetized during the exposures, thereby altering the normal 
respiration rate and tidal volume of the mice. The following experiments address these caveats 
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through use of a multi-animal (n=15), nose-only, acoustical generator exposure system that 
allows for real-time analysis of particle size, deposition estimations, and manipulation of 
exposure concentrations. Furthermore, naïve female BALB/c mice were used in these studies to 
characterize the immune responses following repeated exposures to dry A. fumigatus conidia. 
The secondary aim of these studies was to identify phenotypic characteristics that may 
impact allergy/asthma induction to further aid in characterizing the immune responses to dry WT 
A. fumigatus conidia. Melanin, a large macromolecular pigment that gives A. fumigatus conidia 
the characteristic blue-green color, is a virulence factor that protects the fungus from innate 
clearance (35, 36). Several studies, using melanin knock-down A. fumigatus mutants, have 
shown that albino conidia are more rapidly cleared from the lungs and are less virulent than the 
wild-type (WT) conidia in a murine model of invasive aspergillosis (37, 38). Melanin has also 
been shown to protect WT conidia from opsonization by the complement pathway, as less C3 
molecules bind to the surface of WT than albino conidia (39). Wild-type conidia are also able to 
quench reactive oxygen species (ROS) produced by innate macrophages and neutrophils (40-42). 
The presence of melanin within the conidial wall has also been shown to inhibit phagolysosome 
acidification, and inhibit host cell apoptosis, thereby providing an environment for the conidia to 
sequester until germination occurs (43, 44). Additionally, albino conidia have been shown to 
induce greater proinflammatory cytokine production, including TNFα and IL-6, which does not 
occur following exposure to WT conidia (45). These results indicate that the presence of melanin 
sufficiently protects WT conidia from innate clearance, allowing for fungal persistence and 
germination within the lungs. Therefore, we hypothesize that melanin may play a role in the 
induction of A. fumigatus-induced allergy and asthma.  
In this study, we sought to develop an immunocompetent murine model of repeated 
pulmonary exposures to A. fumigatus conidia that more closely resembles natural environmental 
fungal exposure. Through use of this model, we characterized the immune response following 
exposure and examined the impact of fungal melanization on the induction of an allergic 
phenotype. To do this, a unique, tightly-controlled, nose-only acoustical generator exposure 
system was developed. With this system, several parameters can be accurately monitored in real-
time, including the: 1) number of particles that are aerosolized, 2) size distribution of the 
bioaerosol (2-5 μm in diameter for A. fumigatus conidia), and 3) calculated estimate in the 
number of conidia that are deposited in the lungs. To determine if fungal melanization has a 
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functional role in the development of fungal-induced allergy or asthma, albino conidia obtained 
from a point mutation in the melanin synthesis pathway mutation, was derived from a clinical 
isolate of A. fumigatus were used. These studies are among the first to characterize the 
pulmonary immune responses following repeated dry fungal exposures in a competent murine 
model which more closely resembles natural exposures. 
 
MATERIALS AND METHODS 
Fungal culture 
 Fungal strains (A. fumigatus B-5233/ATCC 13073 - the wild-type (WT) parent strain and 
Δalb1) were received as a gift from Dr. June Kwon-Chung (NIAID, Bethesda, MD). Fungal 
cultures were grown for 14 days at 25°C on malt extract agar. A modified method was used to 
grow conidia for acoustical generator experiments (46). Briefly, 200 ml of dry brown rice 
(Mahatma, Allentown, PA) was autoclaved for 30 minutes at 121°C. Sterilized, distilled, 
deionized water (10 ml) was added to one malt extract plate, and conidia were suspended 
through agitation with a sterile inoculating loop. The fungal suspension was then used to 
inoculate to the autoclaved rice, and 100 mL of additional sterile water was also added to 
completely submerge the rice. The rice/A. fumigatus suspension was stirred and decanted from 
the rice into a sterile 50 ml conical tube. Test MEA plates were also prepared from the fungal 
suspension to ensure there were no contaminant sources. Approximately 10-12 g of rice was 
added to sterile 100 mm petri dishes, and 4 ml of the decanted fungal suspension was added to 
each plate. Plates were wrapped in parafilm and incubated at 25°C for 10-14 days prior to use. 
Plates were shaken daily to dislodge rice aggregates.  
 
Animals 
Female BALB/c mice, aged 5-7 weeks (Jackson Laboratory, Bar Harbor, ME), were 
acclimated for approximately one week before initial exposures. The mice were housed in 
filtered, ventilated polycarbonate cages in groups of five on autoclaved hardwood chip bedding. 
The temperature in the animal facility was maintained between 68°F and 72°F and the relative 
humidity between 36% and 57%. The light/dark cycle was maintained on 12-hour intervals. 
Mice were provided with NIH-31 modified 6% irradiated rodent diet (Harlan Teklad) and tap 
water ad libitum. Sentinel mice were free of viral pathogens, parasites, mycoplasmas, 
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Helicobacter, and CAR. The NIOSH animal facility is an environmentally controlled barrier 
facility that is fully accredited by the Association for the Assessment and Accreditations of 
Laboratory Animal Care International. All animal procedures were performed under a NIOSH 
Animal Care and Use Committee approved protocol 12-BG-M-003. 
 
Animal Exposures 
A nose-only inhalation exposure system was developed to expose mice to unaltered A. 
fumigatus conidia. Air from a water seal compressor was conditioned by passing it through a 
dryer, a charcoal filter, and then a high efficiency particulate air (HEPA) filter. The air stream 
was then run through a mass flow controller (GFC37, Aalborg, Orangeburg, NY) that regulated 
the air flow (6 L/min) in the exposure chamber (Figure 3.1A). The conditioned air flowed 
through a modified PITT-3 acoustical aerosol generator. The acoustical generator consists of a 
speaker covered with a rubber membrane, upon which rice cultures were placed and allowed to 
settle 12-24 hours prior to exposure. The generator used the acoustical energy of a speaker to 
vibrate the conidia laden rice. This resulted in the detachment, deaggregation and aerosolization 
of the spores within the generator. The air-conidia mixture was then passed into a modified nose-
only exposure chamber (Intox Products, LLC, Moriarty, NM). The conidia entered the top of the 
chamber into a column that spanned the chamber’s height. Animals were positioned in separate 
pods that projected out radially from the column. The conidia entered the pods through a port 
directly in front of the nose of the animals. Exhaled air exited via radial ports around the nose of 
the mouse and into a second column where the air was HEPA filtered and fed into the house 
exhaust. The nose-only unit could house up to 24 pods, but only 15 mice were exposed at each 
sampling interval. Two additional pods served as sample ports. The first sample port was used to 
gravimetrically measure the mass concentration of the conidia during an exposure. The second 
sample port was connected to a light scattering device (DataRAM4, ThermoElectron Co., 
Franklin, MA) that provided a real-time estimate of the mass concentration of the conidia in the 
exposure chamber. Additionally, the DataRAM also measured the system temperature and 
humidity. During test runs, the gravimetric sample port was used to collect samples for electron 
microscopy and to size the particles with an aerodynamic particle sizer (APS, TSI Inc., 
Shoreview, MN). The resulting micrographs and APS measurements confirmed that the spores 
retained morphological attributes and largely consisted of a single spore suspension consisting of 
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amerospores (2-4 μm). The mass concentration estimates derived from the DataRAM were also 
shown to correlate with the number of spores within the exposure chamber (APS measurements).  
A lung deposition model was developed based on mice deposition measurements from 
Raabe et al. (47). This allowed for estimation in the number of conidia deposited within the 
murine lung given the size distribution of the fungal aerosols. A scale factor was established and 
applied to the DataRAM signal that estimated the concentration of conidia deposited in the 
mouse lung per unit time. The integrated value of deposited conidia was calculated throughout 
murine exposures and the system automatically turned off the aerosol generator when the target 
conidial concentration was reached (~100 min). Custom software was developed by Travis 
Goldsmith to provide a graphical user interface to monitor, record, and change exposure 
variables. The conidial mass concentration was regulated during exposure intervals through the 
use of software feedback loops. During exposures, control animals were placed in a similar 
control chamber which resided next to the fungal exposure chamber. All environmental 
conditions were kept constant for control animals. 
 Animals were pre-bled via tail vein nick prior to exposure. Mice were also acclimated to 
the exposure chamber by placing them in the nose-only housing units for increasing time, up to 
two hours, over the course of two weeks prior to the first exposure. The aim of this protocol was 
to reduce the stress conditions that may result from the prolonged restraint required for the 
fungal exposures. For exposures, fifteen mice per time point were placed in the control chamber 
(exposed to HEPA filtered air only) or were exposed to WT, or Δalb1 conidia. Mice were placed 
individually in nose-only exposure units attached to the acoustical generator for approximately 2 
hours until real-time particle counts reached 5 x 105 conidia. Mice were exposed twice per week 
(3-4 days apart) for 4 total weeks, and sacrificed at 4, 24, 48, or 72 hours post-final exposure via 
intraperitoneal injection of sodium pentobarbital (Sleepaway®, Fort Dodge Animal Health, Fort 
Dodge, IA). Sera were also collected from each mouse at the time of sacrifice via cardiac 
puncture. 
 
Field emission scanning electron microscopy of aerosolized conidia 
 A sample of 14 day old rice cultures was aerosolized, and A. fumigatus conidia were 
sampled onto a polycarbonate filter from the nose-only chamber. The sample was air dried for 
three days, attached to an aluminum mount with double-stick carbon tape, and sputter coated 
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with gold/palladium. Images were collected on a Hitachi (Tokyo, Japan) S-4800 field emission 
scanning electron microscope. 
 
Modified local lymph node assay 
 Mice were exposed to 5 x 103, 1 x 104, 1 x 105, or 1 x 106 WT conidia or HEPA filtered 
air only via the acoustical generator exposure chamber once daily for three days, and then rested 
for two days. To serve as a positive control for exposures, a group of mice were exposed to 200 
µg of hyphal extract via pharyngeal aspiration using the same exposure schedule. On the sixth 
day, mice were injected i.v. via the lateral tail vein with 20 μCi 3H-thymidine (Dupont NEN, 
Waltham, MA; specific activity 2 Ci/mmol). Five hours following 3H-thymidine injection, 
animals were euthanized via CO2 inhalation. The mediastinal lymph nodes, located at the 
bifurcation of the bronchi in the lung, were removed for analysis. Lymph nodes were 
homogenized between frosted microscope slides, cell suspensions were prepared, and samples 
were incubated with 5% trichloroacetic acid overnight at 4°C. Samples were then mixed with 
scintillation fluid and counted using a Tri-Carb 2500TR liquid scintillation counter. Stimulation 
indices (SIs) were calculated by dividing the mean disintegrations per minute (DPM) by the 
mean DPM obtained from the control chamber exposure mice. Pre- and post-weight data was 
additionally recorded to assess potential toxicity. Concentrations of conidia that induced greater 
than 10% weight loss were not considered for the repeated exposures, despite the SI value. 
 
Airway reactivity assessment 
 Plethysmography experiments were included to determine non-specific airway reactivity 
at 24 and 48 hours following the final conidia exposure (n = 8). Eight control and 8 exposed 
mice were examined at both 24 and 48 hour time intervals. Briefly, mice were placed in 
individual units and allowed to acclimate for 5-10 minutes prior to taking a baseline respiratory 
reading. Baseline values were collected for 5 minutes, followed by the addition of 10 mg/ml of 
methacholine that was added to the nebulizer and exposed to the mice for 3 minutes. Following a 
2 minute recovery, mice were then exposed to 25 mg/ml and 50 mg/ml methacholine, during 
which time data was continuously collected. Enhanced respiratory pause (PenH) values were 
collected as an average value calculated over the 5 minute course of exposure to each 




From each A. fumigatus strain used for exposure, three mice per time point were 
sacrificed at 4, 24, 48, or 72 hours post final exposure. Samples for histology were prepared as 
indicated in Chapter 2. Tissue processing, embedding, hematoxylin and eosin (H&E) and 
Grocott's Methenamine Silver (GMS) staining was performed by the West Virginia University 
Tissue Bank (Morgantown, WV).  
 Swollen and germinating conidia in GMS slides data were acquired by counting the 
number of conidia visualized over 100 different fields of view (40X magnification), covering the 
all lobes of both lungs. Conidia 2-3X the size of resting conidia were classified as swollen. Data 
are presented as the total conidial counts over exposure duration or the percentage of conidia that 
are germinating ((swollen conidial counts + germ tube counts)/ total number of conidia counted).  
 
Collection of BALF and mediastinal lymph nodes 
BALF collection was completed as indicated in Chapter 2 and prepared for flow 
cytometric analysis. Following centrifugation of the BALF at 860 x g for 2 minutes, the 
supernatant was retained and frozen at -20°C for complement analysis. Following collection of 
BALF, the mediastinal lymph nodes were removed from each mouse and suspended in 1 ml of 
sterile PBS. These samples were then homogenized by grinding the nodes between frosted 
microscope slides. The lymph node samples were centrifuged for 3 minutes at 860 x g and the 
supernatant was discarded. Cells isolated from the lymph node were prepared for flow 
cytometric analysis. 
 
Flow Cytometric Analysis: Differential cell staining 
 All reagents were obtained from BD Biosciences (BD Biosciences, San Jose, CA) unless 
otherwise specified. BALF cell composition was determined by flow cytometric analysis of 
recovered lavage cells in suspension. BALF was centrifuged for 3 minutes at 860 x g, the 
supernatant discarded, and the cell pellet resuspended and washed in 1 ml of FACS buffer (PBS, 
5% fetal bovine serum, and 0.05% sodium azide). The washed pellet was resuspended, and 
divided in half for cell enumeration and intracellular cytokine staining. One half of the cells were 
stained in FACS buffer, 10% rat serum, Fc-receptor blocking antibody (clone 24G2) and the 
following antibodies at 1:100: rat anti-mouse Ly-6G, rat anti-mouse Siglec-F, pan-leukocyte rat 
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anti-mouse CD45, and rat anti-mouse CD11c. Mediastinal lymph nodes were also surface 
stained, to identify B cell populations, in FACS buffer, 10% rat serum, Fc-receptor blocking 
antibody (clone 24G2), and B220/CD45R and IgE antibodies. After staining 30 minutes on ice in 
the dark, cells were washed with FACS buffer and fixed with BD Cytofix for 10 minutes. Cells 
were then washed and resuspended in FACS buffer for flow cytometry. Populations of cells were 
evaluated by flow cytometric analysis on a BD LSRII equipped with FACSDiva software(BD 
Biosciences, San Jose, CA). Cells were collected for one minute or until 50,000 events were 
captured. Neutrophils were defined as CD45hiLy-6GhiCD11clow, eosinophils as Ly-
6GlowSiglecFhiCD11clow, and alveolar macrophages as Ly-6GlowSiglecFhiCD11chi, as previously 
reported (48). Total cell numbers were quantified using acridine orange nuclear staining and an 
automated cell counter (Cellometer AutoX4, Nexcelom Bioscience, Lawrence, MA). Total 
numbers of each cell population were obtained by multiplying the frequency of specific 
population by the total number of BALF cells recovered for each animal. 
 
Flow cytometric analysis: Intracellular cytokine staining 
 BALF T-cells were quantified using rat anti-mouse CD8 and CD4 antibodies. T-cell 
cytokine production was determined by fluorescent intracellular cytokine staining (ICS) as 
previously described (49). Briefly, the BALF and mediastinal lymph node suspensions were 
centrifuged for three minutes at 2000 xg and washed in 1 ml of RPMI 1640 complete medium 
(GIBCO, Grand Island, NY) supplemented with 10% fetal calf serum, Pen/Strep/Glutamine, and 
0.05% β-mercaptoethanol. The supernatant was discarded and a solution of Leukocyte 
Activation Cocktail with GolgiPlug in 0.2 ml complete medium was added to each sample for 
stimulation of cytokine production and simultaneous inhibition of cytokine secretion. Cells were 
incubated at 37°C in 5% CO2 for four hours. Following incubation, the BALF cells were washed 
in FACS buffer and stained for flow cytometry analysis using rat anti-mouse CD4, rat anti-
mouse CD8, rat anti-mouse B220/CD45R, and rat anti-mouse CD25 on ice in the dark for 30 
minutes. Mediastinal lymph node cells were stained using rat anti-mouse CD3e, rat anti-mouse 
CD4, and rat anti-mouse CD8 antibodies. Cells were then washed in FACS buffer and 
centrifuged, and the cell pellets were resuspended in BD Cytofix/Cytoperm for 10 minutes to 
allow for fixation and permeabilization required for subsequent ICS. Cells were washed with 1 
ml of BD PermWash, and resuspended in PermWash. Each BALF sample was stained with rat 
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anti-mouse IFN-γ, rat anti-mouse IL-13, rat anti-mouse IL-5, rat anti-mouse IL-22, rat anti-
mouse IL-10, and rat anti-mouse IL-17A (eBioscience, San Diego, CA). Mediastinal lymph 
nodes were stained with rat anti-mouse IL-13, Armenian hamster anti-mouse IL-9 (Biolegend, 
San Diego, CA), rat anti-mouse IL-10, rat anti-mouse IL-12, rat anti-mouse IL-22, rat anti-mouse 
IL-17A, and rat anti-mouse IFN-γ. All antibody concentrations were 1:100. Cell populations 
were analyzed on a BD LSRII, with lymphocytes gated on the basis of low forward and side 
scatter, then subsequently gated on CD4+ or CD8+ populations to determine intracellular 
expression of cytokines. 
 
Preparation of conidial protein extracts 
Conidial extracts, from WT, Δarp2, and Δalb1, were obtained from 14 day old MEA 
plates grown as indicated in Chapter 2. Conidia were harvested from the plates by adding 5 ml of 
sterile, distilled, deionized water, and agitating the surface of the agar with a sterile inoculating 
loop. Samples were frozen overnight at -80°C, and then lyophilized for 3-5 days to remove the 
suspension solution. Glass beads (0.5 mm) were added to each sample. Conidia were then 
subjected to 3 x 1 minute bead beating cycles using a mini-bead beater (BioSpec, Bartlesville, 
OK). Sodium bicarbonate buffer (pH 8.0, 2 ml), containing 0.5 mM EDTA and protease 
inhibitors (Complete Mini, Roche Diagnostics, Indianapolis, IN), was added and the samples and 
then agitated by  three one-minute bead-beating cycles, centrifuged, and the resulting supernatant 
was used for SDS-PAGE. Protein concentrations were estimated using 1.5 µl of extract for 
NanoDrop analysis at 580 nm (NanoDrop, Wilmington, DE).  
 
Western blot analysis 
 Conidial extracts (30 μg) were mixed with Laemmli's (Bio-Rad, Hercules, CA) sample 
buffer and heated at 95°C for 5 minutes. Samples were loaded in individual lanes (30 µg/well) 
and resolved using a 12% polyacrylamide gel with a 4% stacking gel run at 100 V for 60-90 
minutes as done in Chapter 2. Proteins were then transferred to a 0.2 µm nitrocellulose 
membrane at 16 V overnight at 4°C. The membrane was then blocked for 1 hour with 3% bovine 
serum albumin (BSA) in Tris-buffered saline (TBS). Pooled polyclonal sera from exposed mice 
was then diluted to the indicated concentration (1:200 or 1:500) in 3% BSA/TBS and incubated 
with the membrane at room temperature for 1 hour with gentle agitation. The blot was then 
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washed 3 times with TBS/Tween and incubated with alkaline phosphatase (AP)-conjugated goat 
anti-mouse IgG heavy and light chain (Promega, Madison, WI), or goat anti-mouse AP-
conjugated IgM (Calbiochem, Billerica, MA)  diluted 1:5000 in 3% BSA/TBS for 1 hour at room 
temperature with gentle agitation, washed. The blot was then washed 3 times with TBS/Tween 
and developed using the alkaline phosphatase substrate, Pierce 1-Step NBT/BCIP Solution 
(Thermo Scientific, Rockford, IL).  
 
Total IgE ELISA 
 Total IgE concentrations in pre-bleed sera and pooled polyclonal sera isolated from 
exposed mice were determined using a total IgE kit, as per the manufacturer’s instructions 
(Biolegend, San Diego, CA). Sera were prepared at 1:10 and serially diluted, and plates were 
read at 450 and 570 nm. Background absorbance values obtained from the 570 nm readings were 
subtracted from the 450 nm values. The standard curve was created from known concentrations 
(0.156 ng/ml - 10 ng/ml) of IgE standards, and unknown IgE sample concentrations were 
extrapolated from the curve. 
 
Data analysis methods 
Analysis of flow cytometric samples was performed with BD FACSDiva software (BD 
Biosciences, San Jose, CA). GraphPad Prism was used for generation of graphs and statistical 
analysis for clearance and conidial germination experiments, and total IgE levels (GraphPad 
Software, La Jolla, CA). The data were analyzed via two way analysis of variance (ANOVA) 
followed by Bonferroni post-test. Statistical analysis of cellularity and intracellular cytokine 
producing cells was performed using SAS version 9.3 for Windows (SAS, Cary, NC). The data 
were log transformed prior to analysis and Proc Mix was used to run a two-way factorial analysis 
of variance (Fungal Exposure by Time). Pairwise comparisons were performed using Fishers 
Least Significant Difference test. Differences between experimental groups were considered 





Preliminary acoustical generator experiments 
 A new exposure system was developed to enable characterization of  the immune 
responses following fungal exposures to dry fungal conidia. The acoustical generator, based on 
the Pitt-3 generator, was used in these studies and has previously been shown to aerosolize 
carbon nanotubes (50). Figure 3.1A shows a schematic of the dry particle generator system. The 
fungal aerosol is directed into a nose-only chamber where a DataRAM, particle counter and 
particle sizer are attached. To determine if the acoustical generator was capable of producing 
aerosolized A. fumigatus conidia in sufficient concentrations, fungal/rice cultures were 
aerosolized. The real-time particle counts showed that greater than 1 x 108 conidia were produced 
(data not shown). Air samples from the exposure chamber were directed onto a polycarbonate 
filter and analyzed via field emission scanning electron microscopy to visually examine the 
generated aerosol. Images showed single and, in some cases, aggregate conidia were aerosolized 
and entered the nose-only chamber (Figure 3.1C). DataRam analysis, showing the size 
distribution of the particles, confirmed these results (Figure 3.1B). Importantly, no aerosolized 
rice grain fragments or hyphal fragments were observed in the electron microscopy images. 




Figure 3.1 Preliminary dry particle generator exposure chamber 
 
Figure 3.1: Preliminary dry particle generator exposure chamber experiments. A) Illustration 
showing the acoustical generator nose-only exposure chamber. Supply air is HEPA filtered and 
directed into the acoustical generator. The acoustical generator is then sent a signal to vibrate at 
a designated frequency which results in the formation of fungal aerosols from rice grains. The 
fungal aerosol is then directed into a nose-only chamber and air is filtered before being sent into 
the exhaust system. A real-time particle counter attached to the computer calculates the 
concentration of fungal particles being deposited into the airways, and the DataRAM reports 
that number to the computer, which can be altered during the exposure to obtain the desired 
deposition concentration. B)  The aerosol particle size distribution produced by the acoustical 
generator. 2-5 μm is the size of single or aggregate A. fumigatus conidia. C) Field emission 
scanning electron microscopy image of A. fumigatus fungal conidia deposited on a 
polycarbonate filter placed in the nose-only chamber. 
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 To determine if generated conidia reached the terminal airways following nose-only 
exposures, as estimated by Rabbe et al., mice were exposed to WT conidia a single time and 
sacrificed immediately following exposure (47). Histopathological assessment showed fungal 
conidia lining the upper respiratory tract and deposited as deep as the smaller airways (Figure 
3.2). These experiments demonstrated the applicability of the acoustical generator to create dry 
fungal aerosols which resulted in the deposition of conidia within the lower respiratory tract in 
murine nose-only exposures. 
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Figure 3.2 Histology showing conidial deposition 
 
 
Figure 3.2: Histology (20X) of conidial deposition in the sinuses and airways following a single 3.5 hour exposure to 1 x 106 conidia 
(estimated using the deposition model) using the acoustical generator nose-only chamber. The left and middle panels include H&E 
stained sections while the far right panels are GMS stained sections to resolve fungal particles. Conidia observed in the lining of the 
sinuses, lumen of the airways, and airways of fungal exposed mice (silver particulate in GMS indicated by arrows) indicating the 
deposition of fungal particles within the lungs. 
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Lymphoproliferation induced by repeated dry A. fumigatus exposures 
 A modified local lymph node assay was conducted to determine if repeated A. fumigatus 
WT exposures induce proliferation of lymphocytes in the mediastinal lymph nodes. Additionally, 
this data was used to determine the optimal dose for future repeated exposure experiments. A. 
fumigatus hyphal extracts were used as a positive control due to the high concentration of known 
proteins/allergens associated with hyphae (as described in Chapter 1).  
Four groups of mice were exposed to different concentrations (5 x 103, 1 x 104, 1 x 105, 
or 1 x 106 estimated lower airway deposition) of WT conidia using the acoustical generator. As 
shown in figure 3.3, lymphocyte proliferation was dose dependent, with 1 x 106 conidia 
(calculated deposition concentration) inducing the highest stimulation index (~100 SI units). 
Mice that were exposed to this dose experienced greater than 10% weight loss over the course of 
the experiment. As a result of the toxicity associated with this exposure dose, 1 x 106 conidia 
were not used for future experiments. Exposures to less than 1 x 106 conidia did not induce 
weight loss and were less toxic when compared to 1 x 106 conidia doses. As a result, 5 x 105 
conidia were chosen for further experiments. This concentration corresponds to the elevated 


















Figure 3.3. Average stimulation indices determined by a modified local lymph node assay. Mice 
were exposed to the indicated deposition concentration of WT conidia. Stimulation indices (SI) 
were calculated as average disintegration per minute of the exposed group/average 
disintegration per minute control group. Horizontal line at SI of 10 is an arbitrary index used to 
determine positive lymphocyte proliferation in these studies. N=10 mice/group. 
  


































































A . fu m ig a tu s C o n id ia - In d u c e d




 Following determination of the optimal exposure concentration, mice were exposed to 
dry aerosols of WT or Δalb1 conidia twice per week for 4 weeks. Antigen-specific airway 
reactivity was examined immediately following exposure using Buxco analysis; however, no 
reactivity was observed. Non-specific airway reactivity following methacholine challenge was 
examined at 24 and 48 hours post-final exposure. The results presented in Figure 3.4 show that 
each fungal strain induced an increased PenH value, which is indicative of an allergic/asthmatic 
phenotype. Interestingly, mice exposed to melanized wild-type fungi had peak PenH values at 48 
hours post-final exposure, while exposures to albino conidia resulted in peak PenH at 24 hours 
(Figure 3.4). These results demonstrate that the presence of melanin in WT A. fumigatus conidia 





















Figure 3.4: Methacholine-induced airway reactivity. Mice (n= 4 mice/group/time point) were exposed dry aerosolized conidia 8 times 
as indicated. Analysis was completed either 24 or 48 hours after the final exposure. Top) dry WT conidia, Bottom)) dry Δalb1 conidia. 
Left panels-24 and 48 hour values, middle panels- 24 hour values only, right panels-48 hour values only. 
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 In order to examine the pathology associated with repeated exposures to dry conidia, 
cross sections of exposed lungs were examined at 4, 24, 48, and 72 hours following the final 
exposure. As shown in figure 3.5, within 4 hours of exposure to WT conidia, there is an increase 
in inflammatory cells within the lungs. Severe inflammation was evident, which predominantly 
affected the bronchioles (Figure 3.5 A and B). The inflammation was primarily characterized by 
the presence of macrophages and giant cell formation. Airway remodeling and fibrosis were also 
observed. Further, there was a marked increase in mucus production and goblet cell hyperplasia. 
By 24 hours, cellular infiltration was largely composed of neutrophils and eosinophils that 
surrounded the bronchioles, mucus production had begun to resolve (Figure 3.5 A and B), and 
granulomas were observed near the larger airways (data not shown). These results were not 
dependent on melanin content. Within 4 hours of exposure, conidia had been transported from 
the airways into the interstitium (Figure 3.5A) and swollen conidia were observed in GMS 
stained slides (Figure 3.5 A, B, and C). Minimal germ tube formation was present at this time 
point in mice exposed to WT conidia (Figure 3.5 A and C). Importantly, fewer intact conidia 
were evident in the lungs of mice exposed to albino conidia, even at 4 hours (Figure 3.5 B and 
C). By 24 and 48 hours, germination of WT conidia was significantly increased compared to 
albino conidia, which had failed to germinate (Figure 3.5 C). By 48 and 72 hours, most 
inflammation had resolved and few conidia remained despite melanin content (Figure 3.5).  
Two mice (out of 60) that were exposed to WT conidia additionally developed torticollis, 
a condition characterized by a head tilt and uncontrollable spinning when picked up by the tail. 
GMS stained cross sections of the middle/inner ear of control chamber, asymptomatic WT 
exposed, and symptomatic WT exposed mice showed macrophage and neutrophil-mediated 
infiltration and conidia/germination only in symptomatic animals (Appendix A5). These 
preliminary data suggest that torticollis may result from A. fumigatus WT-induced inner ear 



















































































Figure 3.5 Histopathology of sections derived from WT and Δalb1 mice at 4h and 24h. 
Representative histopathology sections from A) WT exposed mice or B) Δalb1 exposed mice 
sacrificed at the indicated time points. Left panels-H&E stained sections at 10X magnification, 
Middle panels-PAS stained sections at 10X magnification, and Right panels-GMS stained 
sections at 40X magnification. Red arrow heads indicate swollen conidia, Black arrow heads 
indicate germination. C) Quantification of conidia and germination (swollen conidia + germ 
tube formation) over time. Values were obtained by quantifying the number of conidia visualized 
at 40X across 100 random fields of view covering both lungs. Conidia were considered swollen 
when the size was 2-3X that of resting conidia.****P ≤ 0.0001, ***P ≤ 0.001, **P ≤ 0.01. 
 
Complement 
 The complement pathway is an innate mechanism that aids in the clearance of A. 
fumigatus conidia. However, complement has not been previously quantified following dry A. 
fumigatus conidial exposures and melanin has been shown to impact the deposition of 
complement proteins. In this experiment, we attempted to quantify the concentration of 
complement protein C3 (the converging point for all three complement pathways) following 
exposure in the BALF supernatant via ELISA. However, the concentration of C3 components in 



















































 Quantification of total BALF cell numbers using flow cytometry showed a statistically 
significant difference in the cellular influx between the different exposure groups over time. 
Mice exposed to WT conidia had significantly higher B cell, macrophage, neutrophil, and 
eosinophil counts in the BALF 48 hours after the final exposure. Furthermore, neutrophils 
remained significantly higher in WT exposed mice by 72 hours (Figure 3.6). Compared to WT 
conidia, BALF cellularity in mice exposed to Δalb1 conidia was generally decreased and peaked 
for many cell types at 4 hours (Figure 3.6). These responses observationally appeared to 
berelated to conidia germination, as the highest numbers in each cell type occurred 48 hours post 
exposure to WT conidia and germination was elevated at this time point. These results also 
suggest that the presence of fungal melanin in WT conidia may have resulted in delayed immune 
cell recruitment to the airway. Interestingly, a downward shift in the alveolar macrophage 
population was also observed, and was more pronounced in WT exposed mice. These data show 
a downward shift in the population suggesting there is an accumulation of macrophages with 
different phenotypes/polarization, which could be classically-activated and alternatively-






















Figure 3.6: Total cell counts in the BALF. Total cell numbers were obtained through acridine orange staining and quantified using an 
automated cell counter. Following 8 dry conidial exposures, mice were sacrificed at the indicated time points to determine the kinetics 
of the cellular influx to the lung. (Control-n=30 mice/time point, Exposed n=7-10 mice/group/time point). ****P ≤ 0.0001, ***P ≤ 

























































4 hr 24 hr 48 hr 72 hr





 To characterize the immune responses that occur following dry conidial exposures, 
intracellular cytokine staining on the BALF cells was performed. CD4 T cell responses were 
significantly higher at 48 hours following WT exposures; however, the levels of these cells were 
similar at each time point in mice exposed to albino conidia. Interestingly, the TH1 type 
CD4+IFN-γ+  and TH2 CD4+IL-13+ T  cells were significantly higher at 24 and 72 hours post-
exposure in mice exposed to albino conidia (Figure 3.7). Mice exposed to WT conidia recruited 
significantly more CD4+IL-17+ T cells to the airways at 48 hours compared to the albino group 
(Figure 3.7). Similar to the responses observed for each cytokine, CD4+TNFα+ and CD4+IL-10+ 
populations were higher at 4 and 48 hours than at 24 and 72 hours in mice exposed to WT 
conidia (Appendix A6). While CD4+TNFα+ levels were not assessed in response to albino 
conidia, CD4+IL-10+ numbers remained similar at each time point (Appendix A6). Aside from 
the CD4+IL-17+ T cells, the remaining CD4 T cell populations that were examined did not appear 
to be affected by germination. 
 Exposures to WT conidia resulted in peak CD8 T cells at 24 hours which decreased over 
time, while exposures to albino conidia induced a reduced response (Figure 3.7). Immediately 
following exposure, there were variable responses as shown by the significantly increased levels 
of CD8+IFN-γ+ and elevated CD8+ TNFα+ and CD8+IL-13+ T cells at 4 hours (Figure 3.7 and 
Appendix A6). CD8+IL-10+ T cell numbers increased as levels of CD8+IFN-γ+ and CD8+ TNFα+ 
declined (Figure 3.7, Appendix A6). Interestingly, CD8+IL-17+ T cells (Tc17) mirrored the total 
CD8 T cells present in the BALF at 24 hours, and were the predominant T cell present at this 
time point (Figure 3.7). These results corresponded to the kinetics of germination as shown in 
figure 3.5C, suggesting that Tc17 cells may specifically respond to and have a function role in 
the clearance of germinating conidia (Appendix A9). Compared to repeated control aspiration 
exposures to silicone beads, these results were specific for A. fumigatus and not the result of 




















Figure 3.7. Intracellular cytokine flow cytometric analysis of the BALF. CD4 and CD8 T cells were quantified by multiplying the 
frequency of each individual cell population by the total cell counts. Mice were sacrificed at the indicated time points after the 8th 
exposure. Data are presented as the average ± standard error of measure. N=7-10 mice/group per time point. ****P ≤ 0.0001, ***P 
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Mediastinal Lymph Nodes Cellularity 
The total mediastinal lymph node cell counts shown in Figure 3.8 are similar to those 
reported for each time point in the BALF analysis. In response to WT exposures, the number of 
lymph node and B cells steadily increased over time with significantly greater cell numbers 
observed at 48 and 72 hours, respectively (Figure 3.8). However, significantly higher lymph 
node and B cell counts, with elevated IgE+ B cells, were observed at 4 hours in the albino 
exposure group. These counts were reduced at 24 hours, and began increasing again at 48 hours 
(Figure 3.8). The sharp decrease in total cell counts, but not B cells, was also observed at 72 

















Figure 3.8: Total cell counts in the mediastinal lymph nodes. Total cell numbers were obtained through acridine orange staining and 
quantified using an automated cell counter. Following 8 dry conidial exposures, mice were sacrificed at the indicated time points to 
determine the kinetics of the cellular influx to the lung-associated nodes. (Control-n=30 mice/time point, Exposed n=7-10 
mice/group/time point). ****P ≤ 0.0001, ***P ≤ 0.001, **P ≤ 0.01, *P ≤ 0.05. 
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 Intracellular cytokine staining was also performed on these samples for flow cytometric 
analysis. CD4+ T cells were significantly increased at 4 hours in mice exposed to albino conidia. 
However, WT exposures resulted in significantly more CD4 T cells at 24 hours. The TH1 
CD4+IFN-γ+ and TH2 CD4+IL-13+ and IL-9+ populations were also significantly elevated in the 
albino exposure groups at 4 hours. This mixed response was delayed in the WT exposure group 
and observed at 24 hours (Figure 3.9 and Appendix A7). While similar patterns were observed in 
CD4+IL-10+ cells, these results were not significant. Importantly, these responses did not appear 
to be dependent on conidial germination  and did not resemble the CD4 T cell responses 
observed in the BALF. 
 LN CD8 T cell responses were also analyzed (Figure 3.9). In the albino exposure group, 
a significant increase in  CD8+IL-13+, CD8+IL-9+, and CD8+IL-10+ T cell responses occurred at 
the 4 hour time point (Figure 3.9 and Appendix A7). Further, CD8+IFN-γ+ counts were greatest 
at 48 hours and remained significantly higher at 72 hours in mice exposed to albino conidia 
compared to WT. CD8+IFN-γ+ responses peaked at 24 hours and decreased over time as well in 
mice exposed to WT conidia, although this response was not statistically significant. TH2 cell 
populations were elevated in the WT exposure group at 24, 48, and 72 hours post exposure when 
compared to the albino group (Figure 3.9). CD8+IL-17+ responses also increased with each time 
interval, and reached maximal levels at 72 hours following the final exposure to WT conidia 
(Appendix A7). Overall, these cell numbers were reduced compared to the total LN counts 
observed in Figure 3.8 . These data did not correlate to the CD8 counts obtained from the BALF 



















Figure 3.9. Intracellular cytokine flow cytometric analysis of the mediastinal lymph nodes. CD4 and CD8 T cells were quantified by 
multiplying the frequency of each individual cell population by the total cell counts. Data are presented as the average ± standard 
error of measure. N=7-10 mice/group per time point. ****P ≤ 0.0001, ***P ≤ 0.001, *P ≤ 0.05 
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 Western blot analysis using sera from exposed mice was conducted to determine if 
specific-antibody was produced following repeated nose-only exposures to dry A. fumigatus 
conidia. The protein profiles from WT and albino conidial extracts were comparable, as shown in 
Chapter 2. Cross-reactivity between the strains was analyzed to determine if exposures to the 
albino conidia induced the production of different antibodies compared to WT. No A. fumigatus-
specific IgM was produced in either group (data not shown). As shown in Figure 3.10A-C, sera 
obtained from WT exposed mice had the greatest number of proteins with IgG-specific reactivity 
compared to the Δalb1 sera; however, 8 proteins were recognized by serum IgG in both WT and 
Δalb1 extracts. Prominent bands were identified at approximately 100 kD, 60 kD, 52 kD, and 
between 10-15 kD. Interestingly, there was strong reactivity with a doublet band in the albino 
extract around 40 kD that was prominently recognized by pooled polyclonal sera from each 
exposure group. The two bands between 10-15 kD were only visible in melanin mutant conidial 
extracts. Furthermore, we observed a potential increase in the IgG titers between 3-7 days, as 
bands were darker in the blots incubated with 7D polyclonal sera (Figure 3.10A-C). 
 Because exposed mice had heightened airway reactivity to methacholine, increased levels 
of TH2 cells in the BALF and LN, and specific-IgG antibody production, it was necessary to 
determine if IgE was also produced to further characterize the immune response following 
repeated exposures. As shown in Figure 3.10D, total IgE concentrations were significantly 
increased in each group, despite the presence of melanin. Similar to the western blot data, IgE 
titers increased by approximately 1000 ng/ml (WT exposed) and 1500 ng/ml (Δalb1) between 
days 3 and 7. Overall, these data indicate that nose-only exposures to dry A. fumigatus conidia 




Figure 3.10 Antibody Production 
 
 
Figure 3.10. IgG and IgE antibody production in wild-type and albino exposed mice. Western blot analysis of serum IgG 
immunoreactive fungal proteins A) WT conidia, or B) Δalb1 conidia. C) Total IgE quantification via ELISA. Sera from exposed m ice 
was obtained at 3 days or 7 days following the final exposure, and analyzed via a commercially available total IgE ELISA kit. Each 





 Previously reported data on the effect of fungal exposures on the murine pulmonary 
immune response has provided valuable insights into the immune mechanisms mediating fungal 
clearance and pathogenesis. However, these exposure models do not reflect natural human 
exposures and were often characterized using immunocompromised murine models. In this 
study, we evaluated the immunocompetent murine immune responses following 8 dry conidial 
exposures. The concentrations used for exposures are similar to those encountered in 
contaminated indoor and occupational environments (2). We developed an innovative acoustical 
generator exposure system to produce homogenous conidial aerosols that could be monitored and 
adjusted in real-time during exposures. The dry particle generator system used in these 
experiments was based on the Pitt-3 aerosol generator, which has previously been used to 
aerosolize cotton dust, low molecular weight particles, and carbon nanotubes (50-52). 
Experiments comparing aspiration exposures to inhalation exposures of carbon nanotubes 
reported exacerbation of pulmonary inflammation and fibrosis in mice that were exposed using 
the acoustical generator. These findings demonstrated the feasibility of using this system for dry 
fungal exposures (50). 
In our system, a nose-only chamber was attached to the acoustical generator to resemble 
a more natural route of human exposures, limit fungal deposition on the body of the mouse, and 
thereby remove any impact that ingestion of fungi may have on the immune response. The ability 
to aerosolize dry conidia with this system also avoided the potential for conidial alterations that 
likely result following the introduction of conidia to liquid suspensions. Furthermore, rice was 
also used as a natural substrate for fungal growth. This limited the likelihood that A. fumigatus 
would produce different immunomodulatory proteins as a result of growth on an artificial, 
nutrient-rich media. This system also allowed for real-time analysis of the aerosol to ensure the 
exposure/deposition concentration and size of respirable particles were consistent. These factors 
have been overlooked in recently published dry A. fumigatus exposure models. Thus, the 
acoustical generator exposure system is an improved method to reproducibly expose mice to 
unaltered, dry A. fumigatus conidia for examination of pulmonary immune responses. 
In this study, 5 x 105 conidia were used for multiple murine exposures. This concentration 
of conidia did not induce toxicity, as determined by > 10% weight loss, yet resulted in the 
highest amount of lymphocyte proliferation as determined by a modified local lymph node assay. 
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Following dry conidial exposures twice weekly for 4 weeks, multiple end points were examined. 
Histopathology analysis showed that severe inflammation occurred within 4 hours of exposure to 
WT conidia, which was mediated primarily by macrophages. At the 4 hour time point, conidia 
were located within macrophages in the surrounding interstitium. Large quantities of mucus in 
goblet cells were evident, bronchiolar pneumonia was observed, and tissue remodeling/fibrosis 
processes were evident. By 24 hours, the inflammation was reduced, yet still evident. Large 
numbers of neutrophils and eosinophils were observed surrounding the larger airways, and giant 
cell formation was apparent, as were granulomas. Inflammation was mostly resolved by 48 and 
72 hours, though fibrotic areas, giant cells, and granulomas were still observed. With conidia, 
many had begun to swell by 4 hours, but few germ tubes were evident. By 24-48 hours, many 
conidia had begun to form longer hyphae; however, by 72 hours, most conidia were cleared. 
These results are consistent with previously published data from other immunocompetent animal 
models of fungal exposures (8, 16, 34, 53). Using melanin mutant strains, these data 
demonstrated that inflammation was not dependent on the extent of melanization, but changes in 
the clearance of conidia were impacted by the melanin content. These findings are in agreement 
with the data presented in Chapter 2.   
Importantly, fewer albino conidia were observed in the histopathology analysis at the 
earlier time points, despite being exposed to equal concentrations. Decreased albino conidia at 5 
hours post aspiration exposure were also reported in Chapter 2. Recent studies have shown that 
epithelial cells lining the respiratory tract contain toll-like receptors (TLRs), including TLR-2 
and TLR-4 that specifically recognize fungal conidia and hyphae, and can result in the 
translocation of transcription factor, NF-κB and the production of proinflammatory cytokines 
(54, 55). The results of these studies suggest that these cells are able to efficiently phagocytose 
and degrade the albino conidia in the upper airways, thereby affecting the deposition of conidia 
within the lungs. Furthermore, it has been hypothesized that the lack of a melanin layer enhances 
the accessibility of important PAMPs, such as β-glucans, that directly impact innate-mediated 
clearance and production of proinflammatory responses through PRRs such as Dectin-1, though 
this has not yet been determined (45). Interactions of accessible PAMPs with innate PRRs would 
greatly influence the rate of clearance, and could offer a potential explanation for the lower 
concentration of albino conidia present at 4 hours post-exposure (12, 54, 56, 57). The lack of 
melanin in the albino conidia may also result in increased susceptibility to innate clearance 
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mechanisms (35, 41, 43). Thus, it is also likely that these conidia are cleared at a much faster rate 
than WT conidia. This finding may also account for the slightly decreased levels of conidia 
observed at 5 hours post aspiration exposure presented in Chapter 2. 
The presence of melanin impacted the recruitment kinetics of immune cells in BALF and 
mediastinal lymph nodes, as total cell numbers peaked at 4 hours in mice exposed to albino 
conidia, but not until 48 hours in WT exposed mice. By 72 hours, cell numbers had decreased to 
slightly above control animals, which was similar to the observed clearance of most conidia by 
this time. These results show that there is a delayed response to melanized conidia, is likely 
related to the ability of melanin to mask and neutralize many innate immune functions. 
Interestingly, a downward shift in alveolar macrophage populations was observed in the flow 
cytometry dot plots of exposed mice. This shift was more evident in mice exposed to WT 
conidia. Alternatively activated macrophages (M2) are present during allergic responses, and 
play a role in tissue repair. Fei et al. have reported that M2 cells are the predominant macrophage 
cell type present, and are induced shortly following exposure to A. fumigatus conidia (8). Given 
the downward shift from the population in control mice, it is possible that this population 
consists of alternatively activated macrophages (M2), though M2-specific surface markers were 
not examined (8).  
Intracellular cytokine analysis of BALF components provided greater insight into the 
pulmonary immune responses following repeated dry conidia exposures. The data demonstrated 
that CD4 and CD8 T cell numbers may be dependent on melanin, as exposures to WT conidia 
resulted in greater numbers of these cell types. Higher levels of CD4 T cell populations were 
observed at 4 and 48 hours post exposure to WT conidia. It is possible that these CD4 T cell 
populations were the result of innate recognition of resting conidia. As conidia began to 
germinate, a secondary CD4 T cell response appeared to occur, potentially as a result of the 
inflammation associated with recognition and clearance of the swollen conidia that occurred 
between 24 and 48 hours post exposure. Further, peak CD4 IL-17 (TH17) production occurred at 
48 hours in mice exposed to WT conidia, which corresponded to the peak neutrophil numbers in 
the BALF. Previous reports have indicated that a major role for TH17 cells includes the 
recruitment of neutrophils, which highlights an important host defense mechanism for induction 
of TH17 cells in the clearance of fungi. Additionally, there was also concomitant TH1 and TH2 
responses over the time course of the study, which has been previously been shown in other A. 
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fumigatus aspiration models. This may have a functional role in the induction of allergy, as over 
time, the TH2 responses can outweigh the inflammatory reactions to limit tissue injury.  
CD4 T cell responses within the lymph nodes of mice exposed to WT conidia increased 
over time, likely indicating the continual antigen presentation, lymphocyte activation, and clonal 
expansion at this site (58, 59). Levels of CD4 IFN-γ (TH1), IL-13 and IL-9 (allergy associated 
TH2), and IL-17 and IL-10 (immunoregulatory cytokines) peaked at 72 hours in mice exposed to 
WT conidia. These data agree with the BALF data, and indicate concurrent TH1 and TH2 
responses. There were minimal differences in these cell numbers in mice exposed to albino 
conidia, with the exception of IFN-γ production. Because melanin is known to dampen 
proinflammatory responses, this result was expected in the BALF (45). However, LN responses 
to albino conidia have not been previously examined. Through murine exposure to Cryptococcus 
neoformans strains with different levels of melanization, Huffnagle et al. observed a marked 
decreased in lymphocyte expansion in the mediastinal lymph nodes and serum antibody 
responses in animals that were exposed the high melanin fungus (60). The authors further 
hypothesized that these results are likely related to the decreased proinflammatory response that 
occurs following exposure to the highly melanized fungus. Taken together with the data 
presented in these studies, A. fumigatus melanin may also dampen adaptive immune responses 
by limiting the induction of proinflammatory lymphocytes. Alternatively, because there are 
fewer albino conidia present at the earliest time point examined, it is also possible that the low 
level of these conidia is below a threshold that induces lymphocyte proliferation. Further 
modified local lymph node assays to determine lymphocyte proliferation following exposures to 
albino conidia are required to clarify this observation.  
There is minimal information available concerning the role of CD8 T cell responses in A. 
fumigatus induced immune responses, although studies have shown that germination can impact 
the production of memory CD8 T cell responses and fungal clearance. In these studies, total 
BALF CD8 T cells increased by 24 hours and then steadily declined over time. CD8 IFN-γ and 
IL-13 production was highest at 4 hours. IL-10 production increased as IFN-γ levels declined, 
which is consistent with the role of IL-10 to limit the inflammatory response. Importantly, Tc17 
cells mirrored the total CD8 T cell numbers, which peaked at 24 hours. These cells were the 
predominant CD8 T cells, comprising approximately 1/3 of the parent population.  
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The importance of Tc17 cells in immune responses to A. fumigatus conidia has not been 
previously shown. As discussed in Chapter 2, Tc17 cells are a unique subset of CD8+ T cells that 
have recently been associated with viral immunity (viral clearance), pulmonary inflammatory 
responses, patients with systemic lupus erythematosus, control of tumor growth, and contact 
dermatitis. Tc17 cells demonstrate functional plasticity, and are reported to produce 
proinflammatory cytokines and chemokines responsible for the enhanced recruitment of 
macrophages, natural killer cells, and neutrophils. Aside from the studies presented in this 
dissertation, these cells have not been previously identified in models of A. fumigatus exposures, 
and may indicate a novel role for Tc17 cells in the immune responses to the fungus. Within 24 
hours of peak Tc17 responses, the maximum numbers of macrophage, neutrophils, and 
eosinophils were present in the BALF. These results are consistent with the reported role for 
Tc17 cells innate cell recruitment. The response was also fungal specific, as exposures to silicone 
beads of the same size as conidia did not induce Tc17 cell responses. Most importantly, the 
increase in Tc17 cells appeared to correlate with an increase in the germination of WT conidia. 
These results demonstrate that Tc17 cells are likely activated and recruited to the lungs of mice 
upon swelling and germination of conidia. 
LN CD8 T cells also increased over time in mice exposed to WT conidia, while mice 
levels were highest at 4 hours, followed by a rapid decrease at 24 hours, and a steady incline over 
time in mice exposed to albino conidia. CD8 IFN-γ production was limited in WT exposed mice, 
though levels peaked at 24 hours followed by a steady decline. Albino conidial exposures 
resulted in higher levels of CD8 IFN-γ than in WT, correlating to data obtained from the BALF. 
Peak responses in CD8 IL-13, IL-9, and IL-10 occurred at 4 hours in mice exposed to albino 
conidia; however, levels dropped off and then steadily increased to 72 hours. The heightened 
levels at 4 hours may be due to a faster rate of albino conidia clearance, which may potentially 
increase the rate of antigen presenting cell trafficking to LN. This may also be compounded by 
the heighted inflammatory responses occurring following exposures to albino conidia. 
Previous data has shown limited antibody responses following repeated aspiration 
exposures; however, it remained unknown if repeated dry exposures would impact antibody 
production. Therefore, we examined mediastinal lymph node B cell cellularity following dry 
exposures. As was indicated in BALF analysis, albino conidia induced the greatest number of B 
cells at 4 hours, followed by a sudden decrease at 24 hours, which followed an upward trend by 
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72 hours. However, LN B cell numbers were highest at the latest time point examined (72 hours) 
post-exposure in WT exposed mice at 72 hours post-exposure. This dual-phase response to 
albino conidia is consistent with ‘classical’ activation of the immune response, with the innate 
effector phase occurring immediately following exposure, and the adaptive phase starting 
approximately 72 hours after re-exposure to the same antigen. As the albino conidia were 
cleared, the overall immune response decreased until any conidia remaining were processed and 
presented within the LN. However, this difference in cellular recruitment at each time point in 
response to albino conidia did not impact the production of antibody. This is likely because LN 
B cell numbers were comparable between the exposure groups at this time point and strongly 
correlated to helper T cell responses, which are required for activation and expansion of B cell 
responses.   
Since total IgE+ B cells were consistently high in mice exposed to WT conidia, specific 
antibody responses, including IgG and IgM reactivity, was analyzed using western blotting. 
Initial experiments indicated that there was no detectable specific-IgM production; however, 
several IgG-reactive proteins were visualized using polyclonal pooled sera from mice sacrificed 
3 and 7 days following the final exposure. Sera from each group were also cross-reactive against 
conidial extracts from each fungal strain, regardless of melanization. Interestingly, WT sera 
reacted strongly with a greater number of bands in the albino extract than in WT or Δarp2 
extracts. These results suggest that additional A. fumigatus-specific antibodies were produced 
that may not have been previously identified, as cross-reactivity against albino conidia has not 
been examined prior to these studies. It is possible that the additional reactive proteins are tightly 
cross-linked to the melanin within the conidial wall, and thus, are diminished in the WT conidial 
extract. Further, the reactive proteins may be more soluble in the albino conidia, and therefore 
are present in higher concentrations in the albino extract, resulting in stronger band intensity 
following western blot analysis. Furthermore, the intensity of the bands were increased in blots 
incubated with sera obtained from mice 7 days post-final exposure. Since antibody production 
accumulates overtime, these results are consistent with the knowledge that maximal adaptive 
immunity and antibody production commonly occurs between 7-10 days after re-exposure (61). 
These results are significant because some allergic conditions caused by frequent fungal 
inhalation are mediated by both IgG and IgE.  
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Total IgE was analyzed in pooled sera obtained from exposed mice at 3 and 7 days post-
final exposure. There was a marked increase in the total IgE present in sera from mice exposed to 
both WT and albino conidia, and this level also increased between days 3-7. Importantly, the 
total IgE levels presented increased nearly 100-fold over those presented by Schuh and 
colleagues, though this is likely a function of exposure duration, as the same strain of A. 
fumigatus WT were used in both studies (34). Taken together, these results indicate that melanin 
does not significantly impact the production of fungal-specific antibodies, nor does it impact the 
induction of allergy in our model. Repeated nose-only exposures to dry conidia, despite 
melaninization, appear to induce allergic phenotypes. Further experiments to identify of the 
specific components that mediate these responses are required for better understanding of the 
fungal allergy induction process. 
In conclusion, we have developed a novel, sophisticated dry fungal aerosol exposure 
system that can be used to characterize the immune responses against environmentally and 
occupationally relevant fungal bioaerosol sources. This is significant because it allows for 
experiments to be completed that more closely model natural human exposures than those 
models that are currently reported in the peer reviewed literature. Furthermore, this exposure 
model also accounts for the potential impact of other cells, which may aid in shaping the 
developing immune response, and were overlooked using aspiration and intratracheal instillation 
models. We have shown that the kinetics of cellular inflammatory response is affected by the 
presence of melanin. Most importantly, results from this study suggest that Tc17 cells recognize 
and may respond to A. fumigatus germination, and are likely the major source of IL-17 
responsible for heightened recruitment of innate phagocytes. All presented results were specific 
to fungi, as exposure to control silicone beads induced innate inflammation which was rapidly 
resolved, and did not result in an increase in T cells in the BALF or LN (data not shown). 
Additionally, we observed the production of specific IgG to numerous immuno-dominant 
proteins. Identification of these biomarker antigens may be useful in improving diagnostics 
through identifying potential biomarkers of exposures/infection/allergy, and in developing 
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Aspergillus fumigatus is a leading cause of invasive disease in immunocompromised 
individuals (1-3). Although A. fumigatus has predominantly been examined in this context, it is 
also responsible for inducing a large number of diseases characterized by persistent colonization 
and the induction/exacerbation of allergy and asthma phenotypes. These adverse health outcomes 
impact a greater population of individuals than invasive disease, and the associated health care 
costs are a major public health burden (4-10). Despite the large population of individuals 
affected by fungal-mediated allergies and asthma, the immunological mechanisms of disease 
induction following repeated fungal exposures in immunocompetent individuals have remained 
largely uncharacterized. To address this knowledge gap in the peer reviewed literature, the 
primary goal of this dissertation was to characterize the immune response(s) following 
subchronic A. fumigatus exposures in an immunocompetent murine model.  
Numerous manuscripts have been published that discuss the impact of A. fumigatus 
exposure on the immune system and these studies have led to the current understanding in the 
field (11, 12). However, many reports only present data derived from in vitro cell culture systems 
(13-26). Those studies that examine the impact of exposure in in vivo systems use animal models 
but these often do not resemble natural human exposures. Further, these reports mainly contain 
data obtained from single exposures in immunocompromised mice and utilize protocols that 
require exposure to either fungal extracts or suspensions of fungal particles. In natural 
environments, humans are exposed to approximately 104 conidia/m3 daily, although the 
concentration may vary greatly based on the geographical location, season, and disturbance to 
colonized surfaces (27). Fungal bioaerosols consist of fungal conidia, hyphae or particulates that 
have been released from environmental substrates. Resting A. fumigatus conidia are 3 um in 
diameter and contain numerous antigenic molecules, which are likely impacted by the growth 
substrate and the metabolic activity of the organism. Upon interaction with liquid, these antigens 
are potentially solubilized or diluted, resulting in the removal of natural PAMPs that may 
influence host-mediated immune recognition. Further, the activation of metabolism in resting 
conidia can be rapid upon interaction with aqueous buffers (28). Upon germination, numerous 
changes occur in the conidial surface structure, accessibility of immunostimulatory proteins, and 
production of immunosuppressive toxins (3). For example, within 3 hours of inoculation in 
Hank’s Balanced Salt Solution, a conidia-specific toxin diffuses from A. fumigatus conidia and 
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inhibits innate immune responses (29). Therefore, the secondary aim of this dissertation was to 
develop an exposure system that accounted for these limiting variables and more closely 
resembled personal exposures to dry fungal particles obtained from natural substrates. 
Repeated exposures to elevated concentrations of fungi leading to antigen persistence are 
hypothesized to be a major factor responsible for allergic sensitization and asthma (7). However, 
aside from host genetic predisposition and the production of antigens during fungal germination, 
mechanisms of allergy and asthma induction following exposure remain largely unknown (6, 8, 
9, 30). Fungal melanin, a known A. fumigatus virulence factor, has been shown to protect conidia 
from innate recognition and clearance (31, 32). Experiments with albino conidia, derived from a 
clinical isolate of A. fumigatus, have shown a decrease in virulence when compared to WT 
conidia (33, 34). WT conidia have also been shown to bind fewer complement C3 molecules 
than albino isolates, leading to decreased opsonization of the fungus (35). Complement 
regulatory molecules, such as Factor H which inhibits complement binding, also bind to WT 
conidia in a melanin-dependent manner (36). This further protects the conidia from complement-
mediated phagocytosis and membrane attack complex-induced lysis. Melanized conidia are also 
able to quench ROS produced by macrophages and neutrophils, the first phagocytes to respond 
to A. fumigatus following inhalation (32, 37-40). Additionally, the presence or absence of 
melanin does not affect phagocytosis (34, 37). However, the melanin in WT conidia has been 
shown to inhibit host cell apoptosis, as well as acidification of the phagolysosome (41, 42). 
Overall, the presence of melanin in A. fumigatus conidia has been shown to protect the fungus 
from innate clearance, leading to persistence within the lungs, which may impact allergy and 
asthma induction. Therefore, the third aim of this dissertation was to examine the influence of 
melanin on the induction of allergy/asthma in a murine model of repeated exposures to WT and 
melanin-deficient A. fumigatus conidia.  
The influence of fungal melanin on the immunocompetent murine immune responses 
following multiple aspiration or dry A. fumigatus conidia exposures was examined in Chapters 2 
and 3 of this dissertation. Chapter 2 characterized the immune responses following 5 aspirations 
(Figure 2.3A) of A. fumigatus wild-type or melanin-deficient strains. This method was used 
because of historical data which showed reproducible and efficient pulmonary antigen delivery. 
Mice were sacrificed at a single time-point, 72 hours after the final aspiration exposure, and 
multiple end points were examined. For Chapter 3, a sophisticated, nose-only acoustical 
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generator exposure system capable of producing dry, natural A. fumigatus conidial aerosols was 
developed. Mice were exposed twice weekly for 4 weeks to WT or the melanin-deficient strains. 
Thus, data obtained from this murine model of repeated exposures more accurately reflects the 
response that occurs following natural exposures. Mice were sacrificed at 4, 24, 48, and 72 hours 
after the 8th exposure to examine the time-dependent influx of different cells to the airways and 
mediastinal lymph nodes.  
Ideally, exposure schedules would have been the same between the two sets of 
experiments; however, the low levels of allergy phenotypes and the lack of detectable serum 
antibody production in mice exposed via aspiration made it difficult to assess mechanisms of 
allergic induction. As a result of the observations in Chapter 2, the exposure schedule was 
lengthened in an effort to enhance allergic responses. Furthermore, the exposure concentration 
was decreased to 5 x 106 conidia (estimated lower airway deposition concentration) in the 
acoustical generator studies due to higher toxicity associated with 1 x 106 conidia. Despite these 
differences in exposure concentrations between the two studies, the histopathology results and 
cellularity were comparable (Appendix Table A2). These results were also similar to those 
published by other laboratories that used varying concentrations in murine exposure models.  
In spite of the variations in exposure schedules and concentrations between Chapter 2 and 
3, several differences were observed (Appendix Table A2). Total BALF counts were similar 
between exposure models, although there was an apparent decrease in neutrophil and eosinophil 
populations in mice exposed to albino conidia via acoustical generation (Appendix Table A2). 
Another marked difference was the number of remaining albino conidia in exposed lungs. Mice 
exposed via aspiration had greater concentrations of conidia remaining at 5 hours after exposure 
than did the same group exposed via the acoustical generator at 4 hours, even when the 
difference in exposure concentrations was taken into account (Appendix Table A2). The 
difference in neutrophil and eosinophil numbers may be due to the lower number of albino 
conidia present within the lung at 4 hours following acoustical generator exposures than were 
observed in albino aspiration exposures. The nose-only dry aerosol exposure chamber accounted 
for the influence that other host-fungal interactions may have had on the overall immune 
response to fungi. The respiratory tract is lined with specialized epithelial cells which have 
recently been shown to specifically recognize, engulf, and degrade A. fumigatus conidia (16, 25, 
43, 44). Conidial germination within these cells is a mechanism used by the fungus during 
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invasive infection (3, 44). Furthermore, A. fumigatus produces proteases and antigens that inhibit 
the ciliary beat frequency of the airway epithelial cells, thereby limiting their removal through 
the mucocilliary escalator. These proteases are thought to break down the tight junctions between 
the epithelial cells, providing a path for invasion into the underlying tissues (24, 45). The 
interaction between epithelial cells and A. fumigatus conidia is mediated through PRRs, 
including TLR-2 and TLR-4, which results in the production of proinflammatory cytokines (46-
49). These cytokines aid in the recruitment of professional phagocytes to the affected site, 
thereby increasing the rate of clearance (3).  
Multiple studies described the presence of inflammasomes within epithelial cells (50, 51). 
Inflammasomes are composed of several cytoplasmic proteins that, under specific signaling 
events including activation of intracellular PRRs, bind together to form complexes. These 
complexes form a signaling pathway that results in the induction or inhibition of different 
transcription factors, most commonly nuclear factor kappa b (NFκB). Although there is limited 
data on the impact of A. fumigatus on inflammasome signaling, we hypothesize that activation of 
different inflammasome complexes within the epithelial cells may impact the type of immune 
response that is activated following A. fumigatus exposures. Most of these studies utilized in 
vitro epithelial cell models, thereby overlooking the sophisticated cellular interactions that occur 
between immune cells and the respiratory epithelium. Therefore, further in vivo analysis of 
epithelial cell responses following A. fumigatus exposures is required to better understand the 
role of these cells in anti-fungal immunity and the influence fungal-epithelial cell interactions 
may have on induction of infection, tolerance, and allergy/asthma. 
CD8 T cell responses (TNFα, IFN-γ, IL-13, and IL-17) did not appear to be impacted by 
the method of conidial exposure. CD4+IFN-γ+ and CD4+TNFα+ counts; however, were increased 
in mice exposed to WT conidia via aspiration when compared to the acoustical generator. These 
levels could be altered due to a greater number of conidia within the lungs of mice exposed using 
aspiration. While murine exposure to different concentrations of conidia has been reported, the 
quantitative differences arising from this variable remain largely uncharacterized. The difference 
in these TH1 cells could also be a function of premature activation of conidia as a result of 
suspension in liquid, though in our studies using rapid sample preparation, no conidial swelling 
was observed. As discussed previously, metabolic activation results in significant changes in the 
conidial surface exposing proinflammatory PAMPs that are highly immunogenic, as well as the 
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release of numerous allergens (9, 24, 52). These fungal-host interactions have been shown to 
result in increases in IFN-γ and  TNFα (3). 
There is limited information concerning the role of CD8 T cells in antifungal immune 
responses. The most significant data obtained from the repeated aspiration exposure model was 
the induction of a special subset of CD8 T cells, Tc17 cells. Tc17 cells have been implicated in a 
number of diseases, including viral clearance, systemic lupus erythematosus, anti-tumor 
responses, contact dermatitis, and pulmonary inflammation (53-58). Tc17 cells have functional 
plasticity and have been shown to rapidly produce proinflammatory cytokines and chemokines 
responsible for the recruitment of macrophages, neutrophils, and natural killer cells. A recent 
study by Nanjappa et al. examined the role of Tc17 cells in vaccine-mediated protection against 
pneumonia caused by the dimorphic fungal pathogens, Blastomyces dermatiditis and 
Histoplasma capsulatum, (59). Although B. dermatiditis and H. capsulatum have varying 
pathogenic phases compared to A. fumigatus, the authors showed that Tc17 cells have a non-
redundant role in protection against B. dermatiditis and H. capsulatum infection. Tc17 cells were 
selectively induced and recruited to the lungs following vaccination with attenuated B. 
dermatiditis, and were required for protection against lung colonization. This response occurred 
even in the absence of CD4 T cells. Furthermore, Dectin-1 and TH1 cytokines were not required. 
The Tc17 cells, however, required neutrophils to mediate protection. In Chapter 2 and 3, the lack 
of Tc17 cells in mice exposed to albino conidia correlated with the decrease in neutrophil 
numbers (59).  Furthermore, these data suggest that Tc17 cells are generated in response to 
conidia germination. Albino conidia appeared to be cleared before they could germinate in these 
models, which is consistent with previous data. However, WT conidia showed signs of 
germination within 4 hours of the final exposure and peaked at 24-48 hours. The extent of 
germination was closely associated with the influx of Tc17 cells to the lungs of exposed mice. 
These results were specific to fungi as exposure to silicone beads did not results in specific T cell 
responses or IL-17 production. The influx of Tc17 cells also appeared to influence neutrophil 
recruitment to the airways; a finding that is consistent with previously published reports on the 
function of IL-17 (60-62). We hypothesize that Tc17 cells, once activated and recruited to the 
lungs, enhance the recruitment of innate cells upon repeated exposure to the same antigen. 
However, because of the limited mechanistic data obtained from these studies, the biological 
relevance of Tc17 cells responses requires further investigation.  
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The production of antibody was another variable that may have been influenced by the 
method of conidial exposure (Appendix Table A2). In these studies, the presence of A. 
fumigatus-specific IgG was examined using ELISA (Chapter 2) and Western blot (Chapter 3). 
There was minimal IgG production detected from the aspiration exposure animals as determined 
by ELISA. ELISAs are a sensitive method for analysis of serum antibodies. However, due to the 
complexity of the protein profile and differential expression/concentrations of proteins in 
conidial extracts, it is possible that lower concentrations of immunoreactive proteins bound to the 
plate during the assay reduced assay sensitivity. IgG reactivity to these proteins were likely 
below the detection limit of the assay, and could not be quantified. In Chapter 3, specific-IgG 
analysis was assessed using Western blotting. Numerous IgG-reactive bands were visualized 
using pooled, polyclonal sera from exposed mice. The identity of these bands was not 
determined by mass spectrometry.  
In a study by Chaudary, several of these bands were identified by (19). The most 
prominent band in our data was a doublet near 40 kD. Aspf22 is a protease with a molecular 
weight of 47.3 kD, and appears as a doublet (19). Several small molecular weight proteins were 
visible in the experiments presented here, which may represent Aspf 7 ( allergen, mw=11.6 kD), 
Aspf8 (acidic ribosomal protein 2, mw=11.1 kD), and Aspf13 (allergen 13/protease, mw=15.9 
kD) (19). Another prominently reactive band was present near 52 kD, which may correspond to 
Aspf12 (heat shock protein, mw=50.5kD) or Aspf18 (serine protease, mw=52.6 kD). 
Furthermore, a predominant allergen associated with A. fumigatus is enolase. The molecular 
weight of this protein is 47.3 kD, which may be the visible band near 40 kD in our studies (19). 
Aspf5 is a metalloprotease with a molecular weight of 68.7 kD, which may correspond to the 
reactive band near 60 kD in the data presented in Chapter 3 (19). While these are the potential 
identities of the bands observed in our studies, definitive mass spectrometry analysis of these 
samples needs to be completed. Total IgE was analyzed in both experiments using ELISA. Total 
IgE levels were elevated in acoustical generator exposed mice when compared to the aspiration 
mice. While it may be likely that nose-only inhalation exposure to dry conidia resulted in 
increased antibody production, due to changes in dose concentration and schedules, it cannot be 
definitively determined that the reason for these differences was due to dry conidial exposures. 
A. fumigatus contains numerous allergens; however, the immunoreactivity of many of these 
proteins remains uncharacterized. The A. fumigatus-specific proteins identified in Chapter 3 
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could be useful biomarkers of A. fumigatus-associated adverse health outcomes, leading to the 
development of more specific and sensitive immunodiagnostic methods. 
WT (green), Δalb1/albino (white), and Δarp2 (tan) strains from a clinical isolate of A. 
fumigatus were used for exposures in both Chapters 2 and 3. However, data acquired from Δarp2 
acoustical generator exposures were not reported due to several confounding factors that made 
the data difficult to interpret. At the time of sacrifice, several control animals were placed in 
cages designated for exposed mice at each respective time point. During sample collection, 
inflammation was observed in the lungs of several control mice, while the lungs of some exposed 
mice did not appear to have any inflammation. During flow cytometry analysis, distinct 
populations of eosinophils and IgE+ B cells were identified in control mice. Historical data 
showed these cell populations were not present in control mice from either aspiration or 
acoustical generator exposures from previous experiments. Furthermore, histopathological 
assessment of several Δarp2 exposed animals from acoustical generator groups showed limited 
inflammation that was indicative of previous exposures, though it was not similar to lung 
sections from exposed mice that were placed in the correct cages. Furthermore, there was limited 
antibody production in these animals. When compared to the data acquired from WT and Δalb1 
exposed mice, these observations demonstrated that there appeared to be a problem during the 
final acoustical generator exposures of Δarp2 mice. As a result, Δarp2 data were removed from 
the analysis in Chapter 3. 
Though the data suggests that the immune responses occurring following exposures to A. 
fumigatus are mixed TH1 and TH2 responses, definitive conclusions on mechanisms/signaling 
pathways involved in these responses could not be determined. However, several additional T 
cells and cytokines were examined in exposures to albino conidia. T cell production of IL-5 
(important in the recruitment of eosinophils), and IL-22 (produced by activated TH17 cells) were 
examined in the BALF. Data indicated each of these cell types were significantly enhanced 
above control levels in response to repeated aerosol exposures. IL-12 producing T cells were also 
examined in the mediastinal lymph nodes to determine if the TH1 response that occurred. IL-17 
and IL-22 were also examined. These cell types were not examined in mice exposed to WT 
conidia, or in the aspiration exposures due to previous limitations of the available flow 
cytometer. However, it would be beneficial to examine these populations to gain further insight 
into the pathways involved in the A. fumigatus-specific immune responses. A clinical isolate of 
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A. fumigatus was used in these studies. However, previous reports have shown that individual 
isolates produce different proteins, proteases, and allergens. Therefore, additional studies using 
environmental isolates would likely lead to the identification of the roles each of these proteins 
play in mediating the immune response to A. fumigatus. This information may aid in determining 
new targets for anti-fungal therapies. 
 While fungal conidia make up a large concentration of microbes present in naturally 
occurring bioaerosols, respirable hyphal fragments are also consistently present in high 
concentrations. It is largely unknown how exposures to these fragments may impact the 
pulmonary immune response, though it has been hypothesized that hyphal fragments are the 
predominant inducers of fungal-specific allergy. Reports by Green et al. have identified these 
fragments as a major source of aeroallergens (63-65), and in some cases, these fragments can 
begin to germinate again once inside the host, leading to the production of more allergens. 
However, there are limited studies that examine the impact of exposures to these fragments in in 
vitro models. Further studies are required to determine how these fragments may influence the 
immune responses in both immunocompetent and immunosuppressed models, particularly in the 
context of allergy and infection, respectively. Therefore, significant information could be 
obtained following repeated exposures to aerosolized hyphal fragments. Experiments were 
conducted to examine the hypothesis; however, we were unable to produce sufficient 
concentrations of 2-5 µm hyphal fragments capable of being deposited in the terminal airways. 
Further experiments are necessary to determine a better method for hyphal fragmentation. 
 Additionally, the studies presented in this dissertation examined the impact of a single 
fungal species; however, other fungi, such as Alternaria, Chaetomium, and Penicillium spp. also 
constitute a large portion of environmental bioaerosols (6, 8, 9, 30, 63, 66). Exposures to these 
fungi have been linked to asthma and allergy, yet the fungal-mediated mechanisms of disease 
induction have not been adequately addressed in peer reviewed literature. Each of these fungi 
contains species-specific antigens that may modulate the immune responses against them. 
Further studies are required to examine these possibilities. Importantly, the acoustical generator 
dry fungal exposure system and end point analyses have been optimized, allowing for adaptation 
of the system to examine immune responses following repeated exposures to other 
occupationally relevant fungi. Additional work will be required to assess the challenges that are 
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likely present due to differences in size, shape, metabolism, and nutrient requirements compared 
to A. fumigatus before these studies can be completed. 
In conclusion, the significant findings reported in this dissertation include: 1) 
identification of a novel cell type, Tc17 cells, which appear to be impacted by conidial 
melanization and potentially conidia germination, 2) validation that melanin is an important cell 
wall component that may be responsible for modulating associated immune responses following 
repeated exposures, 3) observation of numerous immuno-reactive proteins that, upon 
identification may result in the development of improved immunodiagnostics and/or infection 
prevention strategies, 4) the presence of melanin does not impact the induction of fungal-specific 
allergies, and 5) development of a new, dry-fungal aerosol nose-only exposure system that more 
closely resembles natural human exposures than commonly used exposure protocols. 
Importantly, the characterization and optimization of the acoustical generator exposure system 
can be adapted to examine the murine immune responses following repeated exposures to other 
clinically and environmentally relevant particles. Information obtained from those studies may 
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Figure A1. Melanin inhibits peak abundance. +MALDI qTOF MS mass spectra of the multi-
charged peak at m/z 4840 illustrating peak abundance inhibition caused by melanin. A) A. 
fumigatus WT spectrum, B) Δarp2 spectrum, and C) Δalb1 spectrum. 
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Summary of Conidia Germination in Lung Tissue  
Exposure Group Total Conidia Swollen Conidia Germ Tubes 
Aspergillus fumigatus WT 4011 281 (7.0%) 29 (0.7%) 
Δarp2 3625 138 (3.8%) 19 (0.5%) 
Δalb1 1210 18 (1.5%) 0 (0.0%) 
 
Supplementary Table S1. Summary of conidial germination in lung tissue. Conidia were 
quantified from 150 different fields of view at 40X magnification for each set of lungs. 



















Figure A3: 80X magnification of GMS stained lung section from mouse exposed to WT conidia. Black arrows indicate resting 






Figure A4. Flow cytometric dot plot representation of alveolar macrophages. Representative images from exposed mice as indicated 
time points were gated for alveolar macrophages (upper right quadrant) and eosinophils (upper left quadrant). As shown in control 
mice at each examined time point, alveolar macrophages remained consistent between mice and times. In mice exposed to WT 
conidia, there was an immediate downward shift in this population (potential M2 cells), which remained evident until 72 hours after 





Figure A5. Ear infection analysis of torticollis mice. Representative GMS stained cross sections of the middle/inner ear of control or 
exposed mice at 40X magnification. Moderate inflammation accompanying germinating conidia are apparent in the inner ear of mice 
with torticollis. These results were not observed in control or asymptomatic mice. Out of 40 mice, only 2 developed symptoms of 



















Figure A6. Flow cytometric analysis of intracellular cytokine production in the BALF. CD4 and CD8 T cells were quantified by 
multiplying the frequency of each individual cell population by the total cell counts. Mice were sacrificed at the indicated time points 
after the 8th exposure. Data are presented as the average ± standard error of measure. N=7-10 mice/group per time point. 
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Figure A7. Intracellular cytokine flow cytometric analysis of the mediastinal lymph nodes. CD4 and CD8 T cells were quantified by 
multiplying the frequency of each individual cell population by the total cell counts. Data are presented as the average ± standard 
error of measure. N=7-10 mice/group per time point. 
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Figure A8. Particulate responses in the BALF and LN following repeated exposures to 2 µm 
silicone beads and flow cytometry gating. Data was acquired at 0, 4, 24, 48, and 72 hours post 
final exposures. Representative data are shown. N=5 mice/group/ time point. As observed in the 
dot plots, limited responses occurred following bead exposures, indicating the results presented 
in Chapter 3 are specific to fungi. 







Figure A9. Correlation between Tc17 cells and Germination. A) Tc17 cell numbers at different 
time points for WT (green bars) and Δalb1 (white) exposed mice (n=7-10 mice/group). B) 
Quantification of germination (swollen conidia + germ tube formation) over time (n=3 
mice/group). Data are presented as the average ± standard error of measure. ****P≤0.0001, 
***P≤0.001, **P≤0.01, *P≤0.05. C) A second order quadratic non-linear regression analysis 
comparing Tc17 cells vs. percent of germination. R2=0.9998 indicating a close correlation 




Appendix Table A2 
Comparison to aspiration 
End Points WT Δalb1 
Total Cell Counts Comparable Comparable 
Eosinophils Comparable Decreased 
Neutrophils Comparable Decreased 
CD4
+















 T cells Comparable Comparable 
CD8
+















 T cells Comparable Comparable 
Conidial Numbers Comparable Comparable 
Germination Comparable Comparable 
Antibody responses Detectable Detectable 
 
Table A2: Endpoint comparisons of dry aerosol exposures vs. aspiration exposures. Those 
highlighted in red indicate dry exposure responses that were decreased compared to aspiration 
responses. Those highlighted in green indicate dry exposure responses that were increased in 
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